The present disclosure relates to orthopaedic prostheses and, specifically, to tibial components in a knee prosthesis.
Orthopaedic prostheses are commonly utilized to repair and/or replace damaged bone and tissue in the human body. For example, a knee prosthesis may include a tibial baseplate that is affixed to a resected or natural proximal tibia, a femoral component attached to a resected or natural distal femur, and a tibial bearing component coupled with the tibial baseplate and disposed between the tibial baseplate and femoral component. Knee prostheses frequently seek to provide articulation similar to a natural, anatomical articulation of a knee joint, including providing a wide range of flexion.
The tibial insert component, sometimes also referred to as a tibial bearing or meniscal component, is used to provide an appropriate level of friction and contact area at the interface between the femoral component and the tibial bearing component. For a knee prosthesis to provide a sufficient range of flexion with a desirable kinematic motion profile, the tibial bearing component and tibial baseplate must be sized and oriented to interact appropriately with the femoral component of the knee prosthesis throughout the flexion range. Substantial design efforts have been focused on providing a range of prosthesis component sizes and shapes to accommodate the natural variability in bone sizes and shapes in patients with orthopaedic prostheses, while preserving flexion range and desired kinematic motion profile.
In addition to facilitating implantation and providing enhanced kinematics through manipulation of the size and/or geometry of prosthesis components, protection and/or preservation of soft tissues in the natural knee joint is also desirable.
A given prosthetic component design (i.e., a tibial baseplate, tibial bearing component, or femoral component) may be provided to a surgeon as a kit including a variety of different sizes, so that the surgeon may choose an appropriate size intraoperatively and/or on the basis of pre-surgery planning. An individual component may be selected from the kit based upon the surgeon's assessment of fit and kinematics, i.e., how closely the component matches the natural contours of a patient's bone and how smoothly the assembled knee joint prosthesis functions in conjunction with adjacent soft tissues and other anatomical structures. Soft tissue considerations include proper ligament tension and minimization of soft tissue impingement upon prosthetic surfaces, for example.
In addition to prosthetic sizing, the orientation of a prosthetic component on a resected or natural surface of a bone also impacts surgical outcomes. For example, the rotational orientation of a tibial baseplate and tibial bearing component with respect to a resected proximal tibia will affect the interaction between the corresponding femoral prosthesis and the tibial bearing component. The nature and amount of the coverage of a tibial baseplate over specific areas of the resected proximal tibia will also affect the fixation of the implant to the bone. Thus, substantial design efforts have been focused on providing prosthetic components which are appropriately sized for a variety of patient bone sizes and are adapted to be implanted in a particular, proper orientation to achieve desired prosthesis performance characteristics.
The present disclosure provides an orthopaedic tibial prosthesis including a tibial baseplate with an asymmetric periphery which promotes proper positioning and orientation on a resected tibia, while also facilitating enhanced kinematics, soft-tissue interaction, and long-term fixation of the complete knee prosthesis. The asymmetric baseplate periphery is sized and shaped to substantially match portions of the periphery of a typical resected proximal tibial surface, such that proper location and orientation is evident by resting the baseplate on the tibia. The baseplate periphery provides strategically positioned relief and/or clearance between the baseplate periphery and bone periphery, such as in the posterior-medial portion to prevent deep-flexion component impingement, and in the anterior-lateral portion to avoid undue interaction between the anatomic iliotibial band and prosthesis components.
In one form thereof, the present invention provides a tibial prosthesis comprising: a distal surface; a proximal surface generally opposite the distal surface, the proximal surface having a lateral compartment and a medial compartment; and a peripheral wall extending between the distal and the proximal surface, the peripheral wall defining; an anterior edge; a lateral posterior edge generally opposite the anterior edge and forming a posterior boundary of the lateral compartment; a medial posterior edge generally opposite the anterior edge and forming a posterior boundary of the medial compartment; a lateral periphery extending from the anterior edge to the lateral posterior edge, the lateral periphery defining a plurality of adjacent lateral arcs, an adjacent pair of the plurality of adjacent lateral arcs defining a first lateral radius and a second lateral radius, respectively, the first lateral radius larger than the second lateral radius by at least 100%, whereby the lateral periphery is relatively boxy; and a medial periphery extending from the anterior edge to the medial posterior edge, the medial periphery defining a plurality of adjacent medial arcs, an adjacent pair of the plurality of adjacent medial arcs defining a first medial radius and a second medial radius, respectively, the first medial radius larger than the second medial radius by less than 75%, whereby the medial periphery is generally rounded.
In another form thereof, the present invention provides a tibial prosthesis comprising: a distal surface; a proximal surface generally opposite the distal surface; and a peripheral wall extending between the distal and the proximal surface, the peripheral wall defining: an anterior edge; a lateral periphery including: a lateral edge defining a substantially perpendicular tangent with respect to the anterior edge, an anterior-lateral corner traversing an angular sweep between the anterior edge and the lateral edge to define a boxy corner periphery having an anterior-lateral corner edge length, and a posterior-lateral corner extending away from the lateral edge and the anterior-lateral corner; and a medial periphery including: a medial edge defining a substantially perpendicular tangent with respect to the anterior edge, an anterior-medial corner traversing an angular sweep between the anterior edge and the medial edge to define a rounded corner periphery having an anterior-medial corner edge length that is longer than the anterior-lateral corner edge length, in which the angular sweep between the anterior edge and the medial edge is similar to the angular sweep between the anterior edge and the lateral edge, and a posterior-medial corner extending away from the medial edge and the anterior-medial corner.
In yet another form thereof, the present invention provides a tibial prosthesis comprising an asymmetric prosthesis periphery, the periphery comprising: an anteroposterior axis dividing the prosthesis periphery into a medial compartment and a lateral compartment; an anterior edge disposed between the medial compartment and the lateral compartment; a lateral posterior edge generally opposite the anterior edge and forming a posterior boundary of the lateral compartment; a medial posterior edge generally opposite the anterior edge and forming a posterior boundary of the medial compartment; a lateral periphery extending from the anterior edge to the lateral posterior edge, the lateral periphery defining: an anterior-lateral are having an anterior-lateral are center; and a lateral arc having a lateral arc center, the lateral arc defining a tangent parallel to the anteroposterior axis; a medial periphery extending from the anterior edge to the medial posterior edge, the medial periphery defining: an anterior-medial arc having an anterior-medial arc center; and a medial arc having a medial arc center, the medial arc defining a tangent parallel to the anteroposterior axis, a mediolateral axis defining the longest line segment within the prosthesis periphery that is also perpendicular to the anteroposterior axis, the anterior-lateral arc center disposed between the mediolateral axis and the anterior edge, the anterior-medial arc center disposed posterior of the mediolateral axis.
The above-mentioned and other features and advantages of this invention, and the manner of attaining them, will become more apparent and the invention itself will be better understood by reference to the following description of embodiments of the invention taken in conjunction with the accompanying drawings, wherein:
Corresponding reference characters indicate corresponding parts throughout the several views. The exemplifications set out herein illustrate exemplary embodiments of the invention, and such exemplifications are not to be construed as limiting the scope of the invention in any manner.
The present disclosure provides an asymmetric knee joint prosthesis which facilitates proper rotational and spatial orientation of a tibial baseplate and tibial bearing component upon a resected proximal tibia, while also offering large-area contact with the resected proximal tibia. The prosthesis permits a wide range of flexion motion, protects natural soft tissue proximate the knee joint prosthesis, and optimizes long term fixation characteristics of the prosthesis.
In order to prepare the tibia and femur for receipt of a knee joint prosthesis of the present disclosure, any suitable methods or apparatuses may be used. As used herein, “proximal” refers to a direction generally toward the torso of a patient, and “distal” refers to the opposite direction of proximal, i.e., away from the torso of the patient.
As used herein, the “periphery” of a tibial prosthesis refers to any periphery as viewed in a top plan view, e.g., in a generally transverse anatomical plane. Alternatively, the periphery of a tibial prosthesis may be any periphery as viewed in bottom plan view, e.g., in a generally transverse plane and looking at the distal surface adapted to contact a resected proximal surface of a tibial bone.
As used herein, the term “centroid” or “geometric center” refers to the intersection of all straight lines that divide a given area into two parts of equal moment about each respective line. Stated another way, a geometric center may be said to be the “average” (i.e., arithmetic mean) of all points of the given area. Stated yet another way, the geometric center is a point in a two dimensional figure from which the sum of the displacement vectors of all points on the figure equals zero.
As used herein, a “disparity” or “difference” between two numerical values (e.g., one value “larger” or “smaller” than another), typically expressed as a percentage, is the difference between the two values divided by the smaller of the two values. For example, a smaller quantity having value 75 and a larger quantity having value 150 would have a percentage disparity of (150−75)/75, or 100%.
Referring to
As used herein, “anterior” refers to a direction generally toward the front of a patient. “Posterior” refers to the opposite direction of anterior, i.e., toward the back of the patient.
In the context of patient anatomy, “home axis” AH refers to a generally anteroposterior axis extending from posterior point CP to an anterior point CA, in which anterior point CA is disposed on tubercle B and medially spaced from tubercle midpoint PT by an amount equal to W/6. Stated another way, anterior point CA is laterally spaced by an amount equal to W/3 from the medial end of mediolateral width W, such that point CA lies on the “medial third” of the anterior tibial tubercle.
In the context of a prosthesis, such as tibial baseplate 12 described below, “home axis” AH refers to an axis oriented with respect to baseplate 12 such that the baseplate home axis AH of baseplate 12 is aligned with home axis AH of tibia T after implantation of baseplate 12 in a proper rotational and spatial orientation (as shown in
Home axis AH of tibial baseplate 12 may be said to be an anteroposterior axis, as home axis AH extends generally anteriorly and posteriorly when baseplate 12 is implanted upon tibia T. Tibial baseplate also defines mediolateral axis AML, which lies along the longest line segment contained within periphery 200 that is also perpendicular to home axis AH of baseplate 12. As described below, home axis AH and mediolateral axis AML cooperate to define a coordinate system useful for quantifying certain baseplate features in accordance with the present disclosure.
The embodiments shown and described with regard to
1. Asymmetry of the Tibial Prosthesis.
Referring now to
Tibial bearing component 14 and tibial baseplate 12 have a particular asymmetry, with respect to home axis AH (shown in
In an analysis of a several human specimens, variations in size and geometry for a variety of anatomic tibial features were observed and characterized. Geometrical commonalties between anatomic features, or lack thereof, were noted. Mean tibial peripheral geometries were calculated based on statistical analysis and extrapolation of the collected anatomical data, in view of the observed geometrical commonalties organized around anatomic home axis AH. These calculated mean geometries were categorized by tibial size.
A comparison between the asymmetric peripheries for the present family of prostheses and the calculated mean tibial geometries was conducted. Based on the results of this comparison, it has been found that substantial tibial coverage can be achieved for a large proportion of patients using tibial components having asymmetric peripheries in accordance with the present disclosure. Moreover, this coverage can be achieved with a relatively small number of sizes, even where particular portions of the prosthesis periphery is intentionally “pulled back” from the tibial periphery in order to confer other orthopaedic benefits. Further, the particular asymmetry of tibial baseplate 12 can be expected to offer such coverage without overhanging any portion of the resected surface.
Thus, periphery 200 including the particular asymmetric profile as described below confers the benefits of maximum coverage, facilitation of proper rotation (discussed below), and long-term fixation as described herein. Such asymmetry may be demonstrated in various ways, including: by a comparison of adjacent radii in the medial and lateral compartments of the asymmetric periphery; by a comparison of the edge length in anterior-medial and anterior lateral corners of the periphery, for a comparable lateral and medial angular sweep; and by a comparison of the location of radius centers for the anterior-medial and anterior-lateral corners with respect to a mediolateral axis. Various comparisons and quantifications are presented in detail below. Specific data and other geometric details of the peripheries for the various prosthesis sizes, from which the below-identified comparisons and quantifications are derived, may be obtained from the draw-to-scale peripheries shown in
Advantageously, the asymmetry of tibial component 12 encourages proper rotational orientation of baseplate 12 upon implantation thereof onto tibia T. As described in detail below, the asymmetry of periphery 200 (
The following examples and data are presented with respect to tibial baseplate 12. However, as described in more detail below, tibial bearing component 14 defines perimeter wall 54 which follows peripheral wall 25 of baseplate 12 except where noted. Thus, it is appreciated that the conclusions, trends and design features gleaned from data relating to the asymmetric periphery of tibial baseplate 12 also applies to the asymmetric periphery of tibial bearing component 14, except where stated otherwise.
Lateral compartment 20 and medial compartment 22 of tibial plateau 18 are dissimilar in size and shape, giving rise to the asymmetry thereof. This asymmetry is designed so that peripheral wall 25 traces the perimeter of the resected proximal surface of tibia T, such that tibial plateau 18 covers a large proportion of the resected proximal tibial surface as shown in
However, certain aspects of the asymmetric shape are designed to intentionally deviate from the calculated anatomical shape to confer particular features and advantages in the context of a complete, implanted knee prosthesis. Referring to
Similarly, the posterior edge of the medial compartment may be “pulled back” from the adjacent edge of tibia T to define gap 58. Gap 58 allows extra space for adjacent soft tissues, particularly in deep flexion as described below. Gap 58 also allows prosthesis 10 to be rotated about a lateral pivot by a small amount, thereby offering a surgeon the freedom to displace medial compartment 22 posteriorly as required or desired for a particular patient. In an exemplary embodiment, gap 58 is about 4 mm.
As described in detail below, the asymmetrical periphery also provides a large overall area for proximal surface 34 of baseplate 12, which creates sufficient space for large contact areas between tibial bearing component 14 and femoral component 60 (
a. Medial/Lateral Peripheral Curvatures
The particular asymmetric shape of tibial plateau 18 (and of tibial bearing component 14, which defines a similar periphery as described below) gives rise to a generally “boxy” or angular periphery in lateral compartment 20, and a “rounded” or soft periphery in medial compartment 22.
Turning to
In the exemplary embodiment of
Similarly, medial compartment 22 includes three separate arcs including anterior-medial corner arc 220, medial edge arc 222 and posterior-lateral corner arc 224, defining angular sweeps 1R, 2R and 3R, respectively having radii R1R, R2R and R3R respectively.
In
In exemplary embodiments, medial and lateral radii may be any value within the following ranges: for medial radius R1RX, between about 27 mm and about 47 mm; for medial radius R2RX, between about 21 mm and about 49 mm; for medial radius R3RX, between about 14 mm and about 31 mm; for lateral radius R1LX, between about 46 mm and about 59 mm; for lateral radius R2LX, between about 13 mm and about 27 mm; for lateral radius R3LX between about 27 mm and about 46 mm; for lateral radius R4LX between about 6 mm and about 14 mm; and for lateral radius R5LX between about 22 mm and about 35 mm.
In exemplary embodiments, medial and lateral angular extents or sweeps may be any value within the following ranges: for medial angle 1RX, between about 13 degrees and about 71 degrees; for medial angle 2RX, between about 23 degrees and about 67 degrees; for medial angle 3RX, between about 23 degrees and about 90 degrees; for lateral angle 1LX, between about 11 degrees and about 32 degrees; for lateral angle 2LX, between about 42 degrees and about 63 degrees; for lateral angle 3LX, between about 23 degrees and about 47 degrees; for lateral angle 4LX, between about 36 degrees and about 46 degrees; and for lateral angle 5LX, between about 28 degrees and about 67 degrees;
The unique asymmetry of periphery 200 defined by tibial plateau 18 can be quantified in multiple ways with respect to the curvatures of lateral and medial compartments 20 and 22 as defined by the arrangement and geometry of lateral arcs 208, 210, 212, 214, 216 and medial arcs 220, 222, 224.
One measure of the asymmetry of periphery 200 is found in a simple comparison of radii R2L and R1R, which are the anterior “corner” radii of lateral and medial compartments 20 and 22 respectively. Generally speaking, a corner of a baseplate periphery may be said to be that portion of the periphery where a transition from an anterior or posterior edge to a lateral or medial edge occurs. For example, in the illustrative embodiment of
A periphery corner may also be defined by a particular angular sweep with respect to an anteroposterior reference axis. Such reference axis may extend posteriorly from an anterior-most point of a tibial prosthesis (e.g., from the center of anterior edge 202 of periphery 200) to divide the prosthesis into medial and lateral halves. In a symmetrical prosthesis, the anteroposterior reference axis is the axis of symmetry.
In the illustrative embodiment of
For example, the anterior-medial and anterior-lateral corners may each occupy the central 45 degree angular sweep of their respective 90-degree angular sweeps as described above. Thus, the anterior-lateral corner of periphery 200 would begin at a position rotated 22.5 degrees counter-clockwise from home axis AH as described above, and would end at 67.5 degrees counter-clockwise from home axis AH. Similarly, the anterior-medial corner would begin at a 22.5-degree clockwise rotation and end at a 67.5 degree clockwise rotation.
It is contemplated that the anterior-lateral and anterior-medial corners may occupy any angular sweep as required or desired for a particular design. For purposes of comparison between two corners in a given prosthesis periphery, however, a comparable angular sweep for the lateral and medial sides is envisioned, i.e., the extent and location of the compared angles may be “mirror images” of one another about an anteroposterior axis. For example, in a comparison of anterior-lateral and anterior-medial radii R2L, R1R, it is contemplated that such comparison is calculated across lateral and medial angular sweeps which each begin and end at similar angular end points with respect to the chosen reference axis (e.g., home axis AH).
As best seen in
Stated another way, the smaller R2LX makes a sharper turn, thereby imparting a relatively more “boxy” appearance to the anterior corner of lateral compartment 20, while the relatively larger radius R1RX makes a more gradual turn that imparts a more “rounded” appearance to the anterior corner of medial compartment 22. In the exemplary nine sizes illustrated in
As described in detail below, this “rounded-medial/boxy-lateral” asymmetry of the anterior corners of tibial plateau facilitates and encourages proper rotational orientation and positioning of baseplate 12 upon tibia T upon implantation by allowing periphery 200 to closely match the periphery of a typical resected tibia T (
As noted above, the small-radius “corner” defined by angle 2L may be considered to have a similar angular sweep as a large-radius “corner” defined by angles 1R, 2R (or a combination of portions thereof) for purposes of comparing the two radii. Given this comparable angular sweep, another measure of the asymmetry defined by the medial and lateral anterior corners is the are length of the corners. More particularly, because medial radii R1RX and R2RX are larger than lateral radius R2LX (as described above), it follows that the medial corner has a larger arc length as compared to the lateral corner are length for a given angular sweep.
Moreover, while the peripheries of lateral and medial compartments 20, 22 are shown as being generally rounded and therefore defining respective radii, it is contemplated that an asymmetric periphery in accordance with the present disclosure need not define a radius per se, but rather could include one or more straight line segments which, on the whole, define asymmetric corner edge lengths in the medial and lateral compartments. Referring to
Yet another way to quantify the asymmetry of the anterior corner arcs (i.e., anterior-lateral corner arc 210 and anterior-medial corner arc 220) is to compare the distance of the lateral and medial radius centers C2L and C1R respectively, from anterior edge 202 and/or mediolateral axis AM. (
Another metric for quantifying the “boxy vs. rounded” asymmetry of periphery 200 is a comparison between ratios of adjacent radii. In the more boxy lateral compartment 20, pairs of adjacent radii define large ratios because the large edge radii (i.e., of lateral anterior edge arc 208, lateral edge arc 212 and lateral posterior edge arc 216) are much larger than the adjacent corner radii (i.e., of anterior-lateral corner arc 210 and posterior-lateral corner arc 214). On the other hand, in the more rounded medial compartment 22, pairs of adjacent radii define small ratios (i.e., nearly 1:1) because the radii of the medial arcs (i.e., anterior-medial corner arc 220, medial edge arc 222 and posterior-medial corner arc 224) are of similar magnitude.
In the illustrated embodiment of
Similarly, medial edge arc 222 defines tangent 222A which is also substantially perpendicular to anterior edge 202. The medial “edge” of periphery 200 may be part of the same are that extends around the anterior-medial corner and/or the anterior-lateral corner, as the medial arcs are similar. Indeed, as noted herein, medial compartment 22 may have a single arc which extends from anterior edge 202 to medial posterior edge 206.
Table 2 shows a comparison between adjacent-radii ratios for lateral and medial compartments 20 and 22. For each adjacent pair of radii, the difference between the radii magnitudes are expressed as a percentage of the smaller radius of the pair, as noted above.
As illustrated in Table 2, the “boxy” periphery of lateral compartment 20 gives rise to disparity values Δ-12L, Δ-23L, Δ-34L and Δ-45L that are at least 42%, 48% or 59%, and as great as 323%, 337% or 362%. It is contemplated that the disparity between a pair of adjacent radii in the boxy periphery of lateral compartment 20 may be any percentage value within any range defined by any of the listed values. It is also contemplated that the lateral disparity values may be substantially higher, as required or desired for a particular application.
Meanwhile, the “rounded” periphery of medial compartment 22 gives rise to disparity values Δ-12R and Δ-23R that are as small as 21%, 23% or 25%, and no greater than 61%, 62% or 74%. It is contemplated that the disparity between a pair of adjacent radii in the rounded periphery of medial compartment 22 may be any value within any range defined by any of the listed values. It is also contemplated that the medial disparity values may be less than 21%, and as little as zero %, as required or desired for a particular application.
Moreover, the boxy shape of lateral compartment 20 and rounded shape of medial compartment 22 is also demonstrated by the number of arcs used to define the portion of periphery 200 in lateral and medial compartments 20, 22. In lateral compartment 20, five arcs (i.e., arcs 208, 210, 212, 204, 216) are used to define the lateral periphery, which is indicative of anterior, lateral and posterior “sides” of a box joined by the relatively sharp transitions of corner arcs 210, 214. On the other hand, medial compartment 22 uses only three radii (i.e., 220, 222, 224), leaving no clear definition of any box “sides” or other transitions. Indeed, it is contemplated that medial compartment 22 could join anterior edge 202 to medial posterior edge 206 by a single radius within the scope of the present disclosure.
b. Surface Area of Medial and Lateral Baseplate Compartments
Referring still to
In an exemplary embodiment, lateral surface area SALX may be as little as 844 mm2 or may be as much as 1892 mm2, or may be any area within the range defined by the foregoing values. In an exemplary embodiment, medial surface area SAMX may be as little as 899 mm2 or may be as much as 2140 mm2, or may be any area within the range defined by the foregoing values.
Surfaces areas SAL and SAM do not include any of the area occupied by PCL cutout 28, as any such area is not within periphery 200. However, the asymmetry of surface areas SAL and SAM arises primarily from the differences in the geometry and placement of arcs 208, 210, 212, 214, 216, 220, 222, 224 rather than from any asymmetry of PCL cutout 28. In the illustrative embodiments of
Thus, it is contemplated that the asymmetry of surfaces areas SAL, SAM are little changed by exclusion of the PCL cutout 28 from the area calculation. As illustrated in
In the illustrative embodiment of
Tables 3 and 4 below illustrate that medial surface area SAMX occupies a greater percentage of the total surface area contained within periphery 200X, regardless of whether PCL cutout 28 is included in the calculation. That is to say, medial fill area 82 is larger than lateral fill area 80 by approximately the same proportion as medial and lateral surfaces areas SAMX, SALX. In the exemplary embodiments of
c. Anteroposterior Extent of Medial and Lateral Compartments
Still another way to characterize and quantify the asymmetry of tibial periphery 200 is to compare the overall anteroposterior extent of lateral and medial compartments 20, 22.
Turning to
This disparity in anteroposterior extent can be said to result from medial compartment 22 extending posteriorly further than lateral compartment 20. In the illustrative embodiment of
As set forth in the right-hand column of Table 5, exemplary embodiments of tibial baseplate 12 may define medial anteroposterior extent DAPMX that is larger than lateral anteroposterior extent DAPLX by as little as 12.1%, 12.2% or 12.4%, and as much as 13.7%, 14.2% or 14.5%. It is contemplated that such disparity between medial and lateral anteroposterior extents DAPMX, DAPLX may be any percentage within any range defined by the listed values of Table 5. Advantageously, the particular asymmetric arrangement of tibial baseplate 12 with respect to anteroposterior extent of lateral and medial compartments 20, 22 facilitates substantially complete coverage of tibia T, without overhanging the edge of tibia T, in a wide variety of patients.
For example, in an exemplary family of prosthesis sizes, at least 60% and as much as 90% coverage of the resected proximal surface is provided by tibial plateau 18 of tibial baseplate 12 when rotation is limited to +/−5 degrees from home axis AH. In a majority of all patients, such coverage is between 75-85%. Coverage of up to 100% may be achieved within the scope of the present disclosure, such as by fully extending the posterior-medial and anterior-lateral coverage of tibial plateau (which intentionally leave gaps between tibial plateau 18 and the periphery of tibia T as noted herein).
The additional posteromedial material of tibial plateau 18 includes chamfer 32, described in detail below with respect to the assembly of tibial baseplate 12 to tibial bearing component 14. Chamfer 32 is formed in peripheral wall 25, such that chamfer 32 forms angle α (
2. Progressive Peripheral Growth Between Implant Sizes
In addition to the asymmetry of each individual size/embodiment of tibial baseplate 12, described in detail above, the present disclosure also provides asymmetry in the way periphery 200 grows from one size to the next. Advantageously, this asymmetric peripheral growth accommodates observed growth trends in tibias T of differently-sized patients, while also preserving the optimal fit and coverage provided by baseplate 12, and offering the other advantages of designs in accordance with the present disclosure as described herein.
In symmetrical peripheral growth, a larger size of baseplate is a scaled-up version of a smaller size and vice-versa. In the present asymmetrical peripheral growth, by contrast, certain parameters of tibial baseplate 12 grow faster than others as the overall size of the baseplate gets larger (i.e., from smallest size 1/A through largest size 9/J). Thus, differently-sized components made in accordance with the present disclosure are not proportional to one another in all respects, in that a larger tibial prosthesis is not proportionally larger than a smaller tibial prosthesis in all aspects.
Referring now to
As illustrated in
In
In
As used herein, a “family” of prostheses refers to a set or kit of prostheses sharing common geometrical and/or performance characteristics. For example, the family of nine tibial baseplates whose peripheries 200X are shown in
Advantageously, in the family or kit of prosthesis peripheries shown in
3. PCL Cutout Aligned with Home Axis and Associated Technique
In the illustrated embodiment, tibial plateau 18 includes PCL cutout 28 disposed between compartments 20, 22, as described above. PCL cutout leaves PCL attachment point CP accessible, thereby allowing the PCL to pass therethrough during and after implantation of tibial baseplate 12. Tibial bearing component 14 (
Thus, the illustrated embodiment of tibial prosthesis 10 is adapted for a cruciate retaining (CR) surgical procedure, in which the posterior cruciate ligament is not resected during implantation of tibial prosthesis 10. Further, as noted above, home axis AH includes reference to PCL attachment point CP when tibial baseplate 12 is mounted upon tibia T. In order to facilitate alignment of home axis AH with respect to tibial baseplate 12 and tibia T, alignment indicia 70A, 70P (
However, it is contemplated that a prosthesis in accordance with the present disclosure may be made for a design in which the posterior cruciate ligament is resected during surgery, such as “posterior stabilized” (PS) or “ultra congruent” (UC) designs. The PS and UC designs may exclude PCL cutout 30 in bearing component 14, thereby obviating the need for PCL cutout 28 in tibial baseplate 12. Continuous material may instead occupy cutout 28 (as schematically shown in
4. Tibial Bearing Component and Deep Flexion Enablement
Turning again to
Referring now to
Inferior surface 36 of tibial bearing component 14 includes recess 46 at the periphery thereof and a tibial bearing locking mechanism (not shown) disposed between lateral and medial articular surfaces 40, 42. Exemplary bearing component locking mechanisms are disclosed in U.S. provisional patent application Ser. Nos. 61/367,374 and 61/367,375, both entitled TIBIAL PROSTHESIS. Recess 46 is sized and positioned to correspond with raised perimeter 24 of tibial plateau 18, and the tibial bearing locking mechanism cooperates with locking mechanism 26 of tibial plateau 18 to fix tibial bearing component 14 to tibial baseplate 12 in a desired position and orientation as described in detail below. However, it is contemplated that tibial bearing component 14 may be affixed to baseplate 12 by any suitable mechanism or method within the scope of the present disclosure, such as by adhesive, dovetail tongue/groove arrangements, snap-action mechanisms, and the like.
As best seen in
R3 defines a slightly smaller radial length as compared to R2L, and R4 defines a slightly smaller radial length as compared to R1R, such that the anterior portion of perimeter wall 54 of tibial bearing component 14 is set back from the anterior portion of peripheral wall 25 (i.e., from anterior edge 202 and adjacent arcs, as described above) of tibial baseplate 12. As with the above-described comparison between radii R2L and R1R, anteromedial radius R4 is substantially larger than anterolateral radius R3.
Given that medial portion 41 of tibial bearing component 14 has a lesser anteroposterior extent compared to medial compartment 22 of tibial plateau 18, medial portion 41 must be biased anteriorly in order for the anterior-medial “corners” of tibial bearing component 14 and tibial plateau 18 to coincide as shown in
Tibial plateau 18 of tibial baseplate 12 deviates from the periphery of tibial bearing component 14 in the posteromedial portion of each component, leaving medial portion 41 incongruent with medial compartment 22 of tibial baseplate 12. More particularly, tibial plateau 18 extends posteromedially to substantially cover the proximal resected surface of tibia T, as shown in
Advantageously, void 52 cooperates with the “pulled back” or incongruent posterior medial edge 206 and posterior medial corner 224, as compared to a typical tibial periphery (described above), to allow the deep flexion orientation to be achieved without impingement of femoral component 60 and/or femur F upon tibial plateau 18 and/or tibial bearing component 14. Soft tissues in the region of void 52 are therefore also accommodated with little or no impingement on the surrounding components.
In addition, the relatively large size of tibial plateau 18 (covering a large proportion of the resected proximal surface of tibia T) also allows tibial bearing component 14 to be relatively large, so that tibial bearing component 14 provides sufficient non-articular surface area at chamfers 32, 50 and around the periphery of lateral and medial articular surfaces 40, 42 to allow relatively large-radius, rounded transitions between articular surfaces 40, 42 and peripheral wall 54 of tibial bearing component 14. These gradual, large-radius transitions prevent undue friction between tibial prosthesis 10 and any surrounding soft tissues which may remain in place after implantation of the prosthesis, such as the iliotibial (IT) band.
In certain ranges of prosthesis articulation, for example, the human iliotibial (IT) band may touch the anterolateral “corner”, i.e., the portion of tibial bearing component 14 having radius R3. Because the anterolateral extent of tibial bearing component 14 follows the anterolateral extent of tibial plateau 18 (as described above), the transition between lateral articular surface 40 and peripheral wall 54 at the point of contact between an IT band and tibial bearing component 14 can have a relatively large convex portion while still leaving sufficient concave space for articular surface 40. This large convex portion results in a large contact area if the IT band does contact tibial bearing component 14, which in turn results in relatively low pressures on the IT band. Further, the anterolateral “pull back” or incongruence between the anterior-lateral corner are 210 of periphery 200 and a typical tibial periphery, described in detail above, allows the corresponding anterior-lateral corner of bearing component 14 to maintain separation from the IT band through a wide range of flexion, and low contact pressures where contact does occur.
However, to any such contact between the IT band and tibial bearing component 14 may be avoided or minimized by designing periphery 200 such that anterior-lateral corner arc 210 and/or lateral edge arc 212 is brought away from the expected periphery of a typical tibia T (as calculated from anatomical data, described above). This extra spacing designed into periphery 200 provides extra clearance for the iliotibial band. In addition, this extra clearance assures that the substantial proportion of prospective patients lacking Gerdy's tubercle, which is an eminence located at the anterior-lateral portion of tibia T, will not experience any “overhang” of tibial plateau 18 beyond the anatomic periphery of resected tibia T.
Thus, generally speaking, tibial prosthesis 10 can be considered “soft tissue friendly” because the edges of tibial bearing component 14 and tibial plateau 18, including chamfers 32, 50, are smooth and rounded, so that any soft tissue coming into contact with these edges will be less likely to chafe or abrade.
Advantageously, the relatively large inferior/distal surface area of tibial plateau 18 facilitates a large amount of bone ingrowth where bone ingrowth material is provided in tibial baseplate 12. For example, baseplate 12 may also be constructed of, or may be coated with, a highly porous biomaterial. A highly porous biomaterial is useful as a bone substitute and as cell and tissue receptive material. A highly porous biomaterial may have a porosity as low as 55%, 65%, or 75% or as high as 80%, 85%, or 90%. An example of such a material is produced using Trabecular Metal™ Technology generally available from Zimmer, Inc., of Warsaw, Ind. Trabecular Metal™ is a trademark of Zimmer, Inc. Such a material may be formed from a reticulated vitreous carbon foam substrate which is infiltrated and coated with a biocompatible metal, such as tantalum, by a chemical vapor deposition (“CVD”) process in the manner disclosed in detail in U.S. Pat. No. 5,282,861 to Kaplan, the entire disclosure of which is expressly incorporated herein by reference. In addition to tantalum, other metals such as niobium, or alloys of tantalum and niobium with one another or with other metals may also be used.
Generally, the porous tantalum structure includes a large plurality of ligaments defining open spaces therebetween, with each ligament generally including a carbon core covered by a thin film of metal such as tantalum, for example. The open spaces between the ligaments form a matrix of continuous channels having no dead ends, such that growth of cancellous bone through the porous tantalum structure is uninhibited. The porous tantalum may include up to 75%, 85%, or more void space therein. Thus, porous tantalum is a lightweight, strong porous structure which is substantially uniform and consistent in composition, and closely resembles the structure of natural cancellous bone, thereby providing a matrix into which cancellous bone may grow to provide fixation of implant [#] to the patient's bone.
The porous tantalum structure may be made in a variety of densities in order to selectively tailor the structure for particular applications. In particular, as discussed in the above-incorporated U.S. Pat. No. 5,282,861, the porous tantalum may be fabricated to virtually any desired porosity and pore size, and can thus be matched with the surrounding natural bone in order to provide an improved matrix for bone ingrowth and mineralization.
5. Trial Tibial Components
Tibial prosthesis 10 may be provided in a variety of sizes and configurations to accommodate different bone sizes and geometries. The choice of one particular size may be planned preoperatively such as through preoperative imaging and other planning procedures. Alternatively, an implant size may be chosen, or a previous size choice modified, intraoperatively. To facilitate proper intraoperative selection of a particular size for tibial prosthesis 10 from among the family of sizes shown in
Referring now to
For example, as shown in
Moreover, perimeter wall 114 of trial prosthesis 100 is substantially identical to peripheral wall 25 of tibial plateau 18, and therefore defines periphery 200 with the same features and shapes of perimeter 200 described above with respect to tibial plateau 18. Thus, trial prosthesis 100 is asymmetrical about home axis AH in a similar manner to tibial plateau 18 of tibial baseplate 12, with the nature of this asymmetry changing across the various other sizes of tibial prosthesis provided in the kit including trial prosthesis 100.
In an alternative embodiment, a trial prosthesis may be provided which extends completely to the posterior-medial edge of the natural tibial resection periphery. Thus, such a trial would substantially completely cover the resected tibial surface, thereby aiding in determination of a proper rotational orientation of the trial (and, therefore, of the final tibial baseplate 12). In this alternative embodiment, the trial prosthesis lacks the posterior-medial “pull back” of tibial plateau 18, described above.
Trial prosthesis 100 includes void indicator 106 disposed at the posterior portion of medial portion 104, consuming a given posteromedial area of superior surface 34 and peripheral wall 25. Void indicator 106 indicates where void 52 (discussed above) will be located with respect to tibia T after implantation of tibial prosthesis 10. Void indicator 106 facilitates proper rotational and spatial orientation of trial prosthesis 100 on the resected proximal surface of tibia T by allowing a surgeon to visually match tibial bearing component 14 with trial prosthesis 100, as described in detail below. In the illustrated embodiment, void indicator 106 is an area of visual and/or tactile contrast with the remainder of tibial plateau 18. This contrast may include, for example, a contrasting color, texture, surface finish, or the like, or may be formed by a geometric discrepancy such as a step or lip, for example.
Referring specifically to
6. Tibial Prosthesis Implantation
In use, a surgeon first performs a resection of tibia T using conventional procedures and tools, as are well-known in the art. In an exemplary embodiment, a surgeon will resect the proximal tibia to leave a planar surface prepared for receipt of a tibial baseplate. This planar surface may define a tibial slope, which is chosen by the surgeon. For example, the surgeon may wish to perform a resection resulting in positive tibial slope in which the resected tibial surface slopes proximally from posterior to anterior (i.e., the resected surface runs “uphill” from posterior to anterior). Alternatively, the surgeon may instead opt for negative tibial slope in which the resected tibial surface slopes distally from posterior to anterior (i.e., the resected surface runs “downhill” from posterior to anterior). Varus or valgus slopes may also be employed, in which the resected surface slopes proximally or distally from medial to lateral. The choice of a tibial and/or varus/valgus slope, and the amount or angle of such slopes, may depend upon a variety of factors including correction of deformities, mimicry of the native/preoperative tibial slope, and the like.
In an exemplary embodiment, keel 16 (
With a properly resected proximal tibial surface, the surgeon selects trial prosthesis 100 from a kit of trial prostheses, with each prosthesis in the kit having a different size and geometrical configuration (as discussed above). Trial prosthesis 100 is overlaid on the resected surface of tibia T. If trial prosthesis 100 is appropriately sized, a small buffer zone 110 of exposed bone of resected tibia T will be visible around the periphery of trial prosthesis 100. Buffer 110 is large enough to allow a surgeon to rotate and/or reposition trial prosthesis 100 within a small range, thereby offering the surgeon some flexibility in the final positioning and kinematic profile of tibial prosthesis 10. However, buffer 110 is small enough to prevent trial prosthesis 100 from being rotated or moved to an improper location or orientation, or from being implanted in such as way as to produce excessive overhang of the edge of trial prosthesis 100 past the periphery of the resected tibial surface. In one exemplary embodiment, for example, trial prosthesis may be rotated from a centered orientation by up to +/−5 degrees (i.e., in either direction), though it is contemplated that such rotation may be as much as +/−10 degrees or +/−15 degrees.
To aid in rotational orientation, trial prosthesis may include anterior and posterior alignment indicia 70A, 70P, which are the same marks in the same location as indicia 70A, 70P provided on tibial plateau 18 as described above. The surgeon can align indicia 70A with anterior point CA and indicia 70P with PCL attachment point CP, in similar fashion as described above, to ensure the anatomical and component home axes AH are properly aligned. Alternatively, a surgeon may use indicia 70A, 70P to indicate a desired deviance from alignment with home axis AH. As noted above, deviation of up to 5 degrees is envisioned with the exemplary embodiments described herein. A surgeon may choose to orient indicia 70A, 70P to another tibial landmark, such as the middle of the patella or the medial end of tibial tubercle B.
Thus, the large coverage of trial prosthesis 100 (and, concomitantly, of tibial plateau 18) ensures that tibial baseplate 12 will be properly positioned and oriented on tibia T upon implantation, thereby ensuring proper kinematic interaction between tibial prosthesis 10 and femoral component 60. If buffer zone 110 is either nonexistent or too large, another trial prosthesis 100 is selected from the kit and compared in a similar fashion. This process is repeated iteratively until the surgeon has a proper fit, such as the fit illustrated in
With the proper size for trial prosthesis 100 selected and its orientation on tibia T settled, trial prosthesis 100 is secured to tibia T, such as by pins, screws, temporary adhesive, or any other conventional attachment methods. Once trial prosthesis is so secured, other trial components, such as trial femoral components and trial tibial bearing components (not shown) may be positioned and used to articulate the leg through a range of motion to ensure a desired kinematic profile. During such articulation, void indicator 106 indicates to the surgeon that any impingement of femoral component 60 and/or femur F upon trial prosthesis 100 at void indicator 106 will not occur when tibial prosthesis 10 is implanted. Once the surgeon is satisfied with the location, orientation and kinematic profile of trial prosthesis 100, peg hole locators 108 may be used to demarcate the appropriate location of peg holes in tibia T for tibial baseplate 12. Such peg holes may be drilled in tibia T with trial prosthesis 100 attached, or trial prosthesis 100 may be removed prior to drilling the holes.
With tibia T prepared for receipt of tibial prosthesis 10, tibial baseplate 12 may be provided by the surgeon (such as from a kit or surgical inventory), and is implanted on tibia T, with pegs fitting into holes previously identified and demarcated using peg hole locators 108 of trial prosthesis 100. Tibial baseplate 12 is selected from the family of tibial baseplates illustrated in
With tibial baseplate 12 installed, tibial bearing component 14 may be coupled with tibial baseplate 12 to complete tibial prosthesis 10. However, once attached, tibial bearing component 14 does not fully cover tibial plateau 18 of tibial baseplate 12. Rather, tibial bearing component 14 leaves a posteromedial portion of tibial baseplate 12 uncovered to create void 52 (as shown in
To accomplish such verification, tibial bearing component 14 is placed side-by-side with trial prosthesis 100, with inferior surface 36 of tibial bearing component 14 in contact with superior surface 112 of trial prosthesis 100. Tibial bearing component 14 will substantially cover superior surface 112, but will not cover void indicator 106. Put another way, peripheral wall 54 of tibial bearing component 14 will trace perimeter wall 114 of tibial trial prosthesis 100, excluding the posteromedial area defined by void indicator 106. If inferior surface 36 of tibial bearing component 14 is a match with superior surface 112 of trial prosthesis 100 except for void indicator 106 (which is left uncovered by tibial bearing component 14), then tibial bearing component 14 is the proper size component and may be confidently installed upon tibial plateau 18 of tibial baseplate 12.
Tibial baseplate 12 may then be implanted upon the proximal surface of tibia T in accordance with accepted surgical procedures. Exemplary surgical procedures and associated surgical instruments are disclosed in “Zimmer LPS-Flex Fixed Bearing Knee, Surgical Technique,” “NEXGEN COMPLETE KNEE SOLUTION, Surgical Technique for the CR-Flex Fixed Bearing Knee” and “Zimmer NexGen Complete Knee Solution Extramedullary/Intramedullary Tibial Resector, Surgical Technique” (collectively, the “Zimmer Surgical Techniques”), copies of which are submitted on even date herewith, the entire disclosures of which are hereby expressly incorporated by reference herein.
When the surgeon is satisfied that tibial bearing component 14 is properly matched and fitted to the installed tibial baseplate 12, bearing component 14 is secured using locking mechanism 26 and the corresponding tibial bearing locking mechanism an appropriate instrumentation (not shown). Proper location and rotational orientation of tibial bearing component 14 upon tibial plateau 18 is ensured by raised perimeter 24 cooperating with recess 46, and locking mechanism 26 cooperating with the corresponding tibial bearing locking mechanism (not shown). Such proper orientation results in medial articular surface 42 being generally anteriorly disposed with respect to medial compartment 22 of tibial plateau 18.
Femoral component 60 may be affixed to a distal end of femur F, if appropriate, using any conventional methods and/or components. Exemplary surgical procedures and instruments for such affixation are disclosed in the Zimmer Surgical Techniques, incorporated by reference above. Femur F and tibia T may then be articulated with respect to one another to ensure that neither femur F nor femoral component 60 impinges upon tibial baseplate 12 and/or tibial bearing component 14 in deep flexion, such as at a flexion angle β of 155° as shown in
While this invention has been described as having an exemplary design, the present invention can be further modified within the spirit and scope of this disclosure. This application is therefore intended to cover any variations, uses, or adaptations of the invention using its general principles. Further, this application is intended to cover such departures from the present disclosure as come within known or customary practice in the art to which this invention pertains and which fall within the limits of the appended claims.
This application is a continuation of U.S. patent application Ser. No. 15/827,654, filed on Nov. 30, 2017 and entitled ASYMMETRIC TIBIAL COMPONENTS FOR A KNEE PROSTHESIS, now issued as U.S. Pat. No. 10,470,889, which is a continuation of U.S. patent application Ser. No. 14/034,937, filed on Sep. 24, 2013 and entitled ASYMMETRIC TIBIAL COMPONENTS FOR A KNEE PROSTHESIS, now issued as U.S. Pat. No. 9,861,490, which is a continuation of U.S. patent application Ser. No. 13/189,336, filed on Jul. 22, 2011 and entitled ASYMMETRIC TIBIAL COMPONENTS FOR A KNEE PROSTHESIS, now issued as U.S. Pat. No. 8,613,775, which claims the benefit under Title 35, U.S.C. § 119(e) of U.S. Provisional Patent Application Ser. No. 61/381,800, filed on Sep. 10, 2010 and entitled TIBIAL PROSTHESIS FACILITATING ROTATIONAL ALIGNMENT, and U.S. Provisional Patent Application Ser. No. 61/367,375, filed on Jul. 24, 2010 and entitled TIBIAL PROSTHESIS, the entire disclosures of which are hereby expressly incorporated by reference herein.
Number | Name | Date | Kind |
---|---|---|---|
3774244 | Walker | Nov 1973 | A |
4016606 | Murray et al. | Apr 1977 | A |
4257129 | Volz | Mar 1981 | A |
4340978 | Buechel et al. | Jul 1982 | A |
4501266 | McDaniel | Feb 1985 | A |
4568348 | Johnson et al. | Feb 1986 | A |
4711639 | Grundei | Dec 1987 | A |
4714474 | Brooks, Jr. et al. | Dec 1987 | A |
4759767 | Lacey | Jul 1988 | A |
4769040 | Wevers | Sep 1988 | A |
4770661 | Oh | Sep 1988 | A |
4795468 | Hodorek et al. | Jan 1989 | A |
4822365 | Walker et al. | Apr 1989 | A |
4936853 | Fabian et al. | Jun 1990 | A |
4944756 | Kenna | Jul 1990 | A |
4944757 | Martinez et al. | Jul 1990 | A |
4950298 | Gustilo et al. | Aug 1990 | A |
4959071 | Brown et al. | Sep 1990 | A |
4963152 | Hofmann et al. | Oct 1990 | A |
5007933 | Sidebotham et al. | Apr 1991 | A |
5047057 | Lawes | Sep 1991 | A |
5047058 | Roberts et al. | Sep 1991 | A |
5059216 | Winters | Oct 1991 | A |
5061271 | Van Zile | Oct 1991 | A |
5071438 | Jones et al. | Dec 1991 | A |
5108442 | Smith | Apr 1992 | A |
5116375 | Hofmann | May 1992 | A |
5133758 | Hollister | Jul 1992 | A |
5137536 | Koshino | Aug 1992 | A |
5147405 | Van Zile | Sep 1992 | A |
5171283 | Pappas et al. | Dec 1992 | A |
5192328 | Winters | Mar 1993 | A |
5194066 | Van Zile | Mar 1993 | A |
5197488 | Kovacevic | Mar 1993 | A |
5219362 | Tuke et al. | Jun 1993 | A |
5226915 | Bertin | Jul 1993 | A |
5236461 | Forte | Aug 1993 | A |
5246459 | Elias | Sep 1993 | A |
5271737 | Baldwin et al. | Dec 1993 | A |
5275603 | Ferrante et al. | Jan 1994 | A |
5282861 | Kaplan | Feb 1994 | A |
5282868 | Bahler | Feb 1994 | A |
5282870 | Moser et al. | Feb 1994 | A |
5290313 | Heldreth | Mar 1994 | A |
5310480 | Vidueira | May 1994 | A |
5326361 | Hollister | Jul 1994 | A |
5344460 | Turanyi et al. | Sep 1994 | A |
5344461 | Phlipot | Sep 1994 | A |
5360016 | Kovacevic | Nov 1994 | A |
5364402 | Mumme et al. | Nov 1994 | A |
5370699 | Hood et al. | Dec 1994 | A |
5387239 | Bianco et al. | Feb 1995 | A |
5387240 | Pottenger et al. | Feb 1995 | A |
5395401 | Bahler | Mar 1995 | A |
5405396 | Heldreth et al. | Apr 1995 | A |
5413604 | Hodge | May 1995 | A |
5413605 | Ashby et al. | May 1995 | A |
5425775 | Kovacevic et al. | Jun 1995 | A |
5445642 | McNulty et al. | Aug 1995 | A |
5458637 | Hayes | Oct 1995 | A |
5470354 | Hershberger et al. | Nov 1995 | A |
5489311 | Cipolletti | Feb 1996 | A |
5507820 | Pappas | Apr 1996 | A |
5549688 | Ries et al. | Aug 1996 | A |
5556433 | Gabriel et al. | Sep 1996 | A |
5571194 | Gabriel | Nov 1996 | A |
5609639 | Walker | Mar 1997 | A |
5609641 | Johnson et al. | Mar 1997 | A |
5609643 | Colleran et al. | Mar 1997 | A |
5609645 | Vinciuerra | Mar 1997 | A |
5613970 | Houston et al. | Mar 1997 | A |
5656785 | Trainor et al. | Aug 1997 | A |
5658341 | Delfosse | Aug 1997 | A |
5658342 | Draganich et al. | Aug 1997 | A |
5658344 | Hurlburt | Aug 1997 | A |
5683470 | Johnson et al. | Nov 1997 | A |
5702463 | Pothier et al. | Dec 1997 | A |
5702464 | Lackey et al. | Dec 1997 | A |
5733292 | Gustilo et al. | Mar 1998 | A |
5755801 | Walker et al. | May 1998 | A |
5755802 | Gerber | May 1998 | A |
5776200 | Johnson et al. | Jul 1998 | A |
5782925 | Collazo et al. | Jul 1998 | A |
5824100 | Kester et al. | Oct 1998 | A |
5824102 | Buscayret | Oct 1998 | A |
5824103 | Williams et al. | Oct 1998 | A |
5871539 | Pappas | Feb 1999 | A |
5871541 | Gerber | Feb 1999 | A |
5871543 | Hofmann | Feb 1999 | A |
5871545 | Goodfellow et al. | Feb 1999 | A |
5879394 | Ashby et al. | Mar 1999 | A |
5906643 | Walker | May 1999 | A |
5911723 | Ashby et al. | Jun 1999 | A |
5928286 | Ashby et al. | Jul 1999 | A |
5964808 | Blaha et al. | Oct 1999 | A |
5968099 | Badorf et al. | Oct 1999 | A |
5976147 | LaSalle et al. | Nov 1999 | A |
6004351 | Tomita et al. | Dec 1999 | A |
6004352 | Buni | Dec 1999 | A |
6010534 | O'neil et al. | Jan 2000 | A |
6013103 | Kaufman et al. | Jan 2000 | A |
6039764 | Pottenger et al. | Mar 2000 | A |
6068658 | Insall et al. | May 2000 | A |
6074425 | Pappas | Jun 2000 | A |
6080195 | Colleran et al. | Jun 2000 | A |
6090144 | Letot et al. | Jul 2000 | A |
6102954 | Albrektsson et al. | Aug 2000 | A |
6102955 | Mendes et al. | Aug 2000 | A |
6123729 | Insall et al. | Sep 2000 | A |
6126692 | Robie et al. | Oct 2000 | A |
6143034 | Burrows | Nov 2000 | A |
6197064 | Haines et al. | Mar 2001 | B1 |
6203576 | Afriat et al. | Mar 2001 | B1 |
6206927 | Fell et al. | Mar 2001 | B1 |
6210443 | Marceaux et al. | Apr 2001 | B1 |
6217618 | Hileman | Apr 2001 | B1 |
RE37277 | Baldwin et al. | Jul 2001 | E |
6258127 | Schmotzer | Jul 2001 | B1 |
6306172 | O'Neil et al. | Oct 2001 | B1 |
6325828 | Dennis et al. | Dec 2001 | B1 |
6379388 | Ensign et al. | Apr 2002 | B1 |
6406497 | Takei et al. | Jun 2002 | B2 |
6413279 | Metzger et al. | Jul 2002 | B1 |
6428577 | Evans | Aug 2002 | B1 |
6436145 | Miller | Aug 2002 | B1 |
6491726 | Pappas | Dec 2002 | B2 |
6506215 | Letot et al. | Jan 2003 | B1 |
6506216 | McCue et al. | Jan 2003 | B1 |
6558426 | Masini | May 2003 | B1 |
6607559 | Ralph et al. | Aug 2003 | B2 |
6623526 | Lloyd | Sep 2003 | B1 |
6632225 | Sanford et al. | Oct 2003 | B2 |
6660039 | Evans et al. | Dec 2003 | B1 |
6702821 | Bonutti | Mar 2004 | B2 |
6709461 | O'neil et al. | Mar 2004 | B2 |
6743258 | Keller | Jun 2004 | B1 |
6755864 | Brack et al. | Jun 2004 | B1 |
6770078 | Bonutti | Aug 2004 | B2 |
6869448 | Tuke | Mar 2005 | B2 |
6923832 | Sharkey et al. | Aug 2005 | B1 |
6942670 | Heldreth et al. | Sep 2005 | B2 |
6953479 | Carson et al. | Oct 2005 | B2 |
6974481 | Carson | Dec 2005 | B1 |
6986791 | Metzger | Jan 2006 | B1 |
7025788 | Metzger et al. | Apr 2006 | B2 |
7060074 | Rosa et al. | Jun 2006 | B2 |
7081137 | Servidio | Jul 2006 | B1 |
7083652 | McCUe et al. | Aug 2006 | B2 |
7153326 | Metzger | Dec 2006 | B1 |
7160330 | Axelson, Jr. et al. | Jan 2007 | B2 |
7189262 | Hayes, Jr. et al. | Mar 2007 | B2 |
7261740 | Tuttle | Aug 2007 | B2 |
7264635 | Suguro | Sep 2007 | B2 |
7294149 | Hozack et al. | Nov 2007 | B2 |
7309362 | Yasuda et al. | Dec 2007 | B2 |
7309363 | Dietz | Dec 2007 | B2 |
7326252 | Otto et al. | Feb 2008 | B2 |
7351263 | Afriat | Apr 2008 | B2 |
7364581 | Michalowicz | Apr 2008 | B2 |
7412897 | Crottet et al. | Aug 2008 | B2 |
7413577 | Servidio | Aug 2008 | B1 |
7442196 | Fisher et al. | Oct 2008 | B2 |
7445639 | Metzger et al. | Nov 2008 | B2 |
7488330 | Stad | Feb 2009 | B2 |
7497874 | Metzger et al. | Mar 2009 | B1 |
7513912 | Hayes, Jr. et al. | Apr 2009 | B2 |
7544211 | Rochetin | Jun 2009 | B2 |
7547327 | Collazo | Jun 2009 | B2 |
7575602 | Amirouche et al. | Aug 2009 | B2 |
7578821 | Fisher et al. | Aug 2009 | B2 |
7585328 | Haas | Sep 2009 | B2 |
7587945 | Crottet et al. | Sep 2009 | B2 |
7591854 | Wasielewski | Sep 2009 | B2 |
7625407 | Akizuki | Dec 2009 | B2 |
7628818 | Hazebrouck et al. | Dec 2009 | B2 |
7632283 | Heldreth | Dec 2009 | B2 |
7632314 | Dietz | Dec 2009 | B2 |
7635390 | Bonutti | Dec 2009 | B1 |
7678152 | Suguro et al. | Mar 2010 | B2 |
7695519 | Collazo | Apr 2010 | B2 |
7695520 | Metzger et al. | Apr 2010 | B2 |
7776085 | Bernero et al. | Aug 2010 | B2 |
7837691 | Cordes et al. | Nov 2010 | B2 |
7850698 | Straszheim-Morley et al. | Dec 2010 | B2 |
8012216 | Metzger | Sep 2011 | B2 |
8065927 | Crottet et al. | Nov 2011 | B2 |
8141437 | Amirouche et al. | Mar 2012 | B2 |
8163028 | Metzger et al. | Apr 2012 | B2 |
8187280 | May et al. | May 2012 | B2 |
8197549 | Amirouche et al. | Jun 2012 | B2 |
8211041 | Fisher et al. | Jul 2012 | B2 |
8245583 | Stein | Aug 2012 | B2 |
8268006 | Meyers et al. | Sep 2012 | B2 |
8317870 | Wagner et al. | Nov 2012 | B2 |
8328873 | Metzger et al. | Dec 2012 | B2 |
8366782 | Wright | Feb 2013 | B2 |
8491589 | Fisher et al. | Jul 2013 | B2 |
8506571 | Chana et al. | Aug 2013 | B2 |
RE44476 | Meyers et al. | Sep 2013 | E |
8568486 | Wentorf et al. | Oct 2013 | B2 |
8574304 | Wentorf et al. | Nov 2013 | B2 |
8591594 | Parisi et al. | Nov 2013 | B2 |
8603101 | Claypool et al. | Dec 2013 | B2 |
8613775 | Wentorf et al. | Dec 2013 | B2 |
8617250 | Metzger | Dec 2013 | B2 |
8628580 | Sanford et al. | Jan 2014 | B2 |
8690954 | Parisi et al. | Apr 2014 | B2 |
8740984 | Hartdegen et al. | Jun 2014 | B2 |
8758444 | Wentorf et al. | Jun 2014 | B2 |
8764838 | Parisi et al. | Jul 2014 | B2 |
8764840 | Sanford et al. | Jul 2014 | B2 |
8795282 | Earl et al. | Aug 2014 | B2 |
8808387 | Hawkins et al. | Aug 2014 | B2 |
8858643 | Parisi | Oct 2014 | B2 |
8932298 | Colquhoun et al. | Jan 2015 | B2 |
8932365 | Parisi et al. | Jan 2015 | B2 |
8979847 | Belcher et al. | Mar 2015 | B2 |
8979936 | White et al. | Mar 2015 | B2 |
8998997 | Ries et al. | Apr 2015 | B2 |
9011459 | Claypool et al. | Apr 2015 | B2 |
9072607 | Parisi et al. | Jul 2015 | B2 |
9131945 | Aram et al. | Sep 2015 | B2 |
9149206 | Claypool et al. | Oct 2015 | B2 |
9173744 | Donno et al. | Nov 2015 | B2 |
9186255 | Parisi | Nov 2015 | B2 |
9192480 | Wentorf et al. | Nov 2015 | B2 |
9204970 | Parisi et al. | Dec 2015 | B2 |
9283082 | Sanford et al. | Mar 2016 | B2 |
9295557 | Wentorf et al. | Mar 2016 | B2 |
9295558 | Parisi et al. | Mar 2016 | B2 |
9308095 | Parisi et al. | Apr 2016 | B2 |
9308096 | Wentorf et al. | Apr 2016 | B2 |
9314343 | Parisi et al. | Apr 2016 | B2 |
9381090 | Wentorf et al. | Jul 2016 | B2 |
9427337 | Claypool et al. | Aug 2016 | B2 |
9492290 | Claypool et al. | Nov 2016 | B2 |
9539116 | Claypool | Jan 2017 | B2 |
9592133 | Toler et al. | Mar 2017 | B2 |
9597090 | Claypool et al. | Mar 2017 | B2 |
9655728 | Parisi et al. | May 2017 | B2 |
9655729 | Parisi et al. | May 2017 | B2 |
9707089 | Grey et al. | Jul 2017 | B2 |
9763794 | Sanford et al. | Sep 2017 | B2 |
9763795 | Parisi et al. | Sep 2017 | B2 |
9763796 | Wentorf et al. | Sep 2017 | B2 |
9763807 | Claypool et al. | Sep 2017 | B2 |
9788954 | Parisi et al. | Oct 2017 | B2 |
9861490 | Wentorf et al. | Jan 2018 | B2 |
9901331 | Toler et al. | Feb 2018 | B2 |
9918844 | Sanford et al. | Mar 2018 | B2 |
9925050 | Parisi et al. | Mar 2018 | B2 |
9925052 | Dai et al. | Mar 2018 | B2 |
10010330 | Claypool et al. | Jul 2018 | B2 |
10092407 | Faccioli et al. | Oct 2018 | B2 |
10188530 | Claypool et al. | Jan 2019 | B2 |
10195041 | Wentorf et al. | Feb 2019 | B2 |
10265181 | Wentorf et al. | Apr 2019 | B2 |
10278827 | Drury | May 2019 | B2 |
10413415 | Parisi et al. | Sep 2019 | B2 |
10470889 | Wentorf et al. | Nov 2019 | B2 |
10500054 | Croll | Dec 2019 | B2 |
10543099 | Sanford et al. | Jan 2020 | B2 |
10575956 | Dai et al. | Mar 2020 | B2 |
10675153 | Byrd et al. | Jun 2020 | B2 |
10835380 | Drury et al. | Nov 2020 | B2 |
20010047210 | Wolf | Nov 2001 | A1 |
20020058997 | O'connor et al. | May 2002 | A1 |
20020072802 | O'Neil et al. | Jun 2002 | A1 |
20020120340 | Metzger et al. | Aug 2002 | A1 |
20020161448 | Hayes, Jr. et al. | Oct 2002 | A1 |
20030055509 | Mccue et al. | Mar 2003 | A1 |
20040019382 | Amirouche et al. | Jan 2004 | A1 |
20040019383 | Beguec | Jan 2004 | A1 |
20040034432 | Hughes et al. | Feb 2004 | A1 |
20040059340 | Serra et al. | Mar 2004 | A1 |
20040064191 | Wasielewski | Apr 2004 | A1 |
20040122441 | Muratsu | Jun 2004 | A1 |
20040153066 | Coon et al. | Aug 2004 | A1 |
20040162620 | Wyss | Aug 2004 | A1 |
20040167537 | Errico et al. | Aug 2004 | A1 |
20040186582 | Yasuda et al. | Sep 2004 | A1 |
20040204765 | Fenning et al. | Oct 2004 | A1 |
20040225368 | Plumet et al. | Nov 2004 | A1 |
20040236429 | Ensign et al. | Nov 2004 | A1 |
20040243244 | Otto et al. | Dec 2004 | A1 |
20040267371 | Hayes, Jr. et al. | Dec 2004 | A1 |
20050055102 | Tornier et al. | Mar 2005 | A1 |
20050096747 | Tuttle et al. | May 2005 | A1 |
20050143831 | Justin et al. | Jun 2005 | A1 |
20050143832 | Carson | Jun 2005 | A1 |
20050177170 | Fisher et al. | Aug 2005 | A1 |
20050019771 | Naegerl | Sep 2005 | A1 |
20050209701 | Suguro et al. | Sep 2005 | A1 |
20050209702 | Todd et al. | Sep 2005 | A1 |
20050246030 | Yao | Nov 2005 | A1 |
20050267485 | Cordes et al. | Dec 2005 | A1 |
20050267584 | Burdulis, Jr. et al. | Dec 2005 | A1 |
20050278035 | Wyss et al. | Dec 2005 | A1 |
20060004460 | Engh et al. | Jan 2006 | A1 |
20060020343 | Ek | Jan 2006 | A1 |
20060030945 | Wright | Feb 2006 | A1 |
20060052782 | Morgan et al. | Mar 2006 | A1 |
20060069436 | Sutton et al. | Mar 2006 | A1 |
20060089653 | Auger et al. | Apr 2006 | A1 |
20060142869 | Gross | Jun 2006 | A1 |
20060161259 | Cheng et al. | Jul 2006 | A1 |
20060184176 | Straszheim-Morley et al. | Aug 2006 | A1 |
20060189864 | Paradis et al. | Aug 2006 | A1 |
20060190087 | O'Connor | Aug 2006 | A1 |
20060195195 | Burstein et al. | Aug 2006 | A1 |
20060111726 | Felt et al. | Oct 2006 | A1 |
20060224244 | Thomas et al. | Oct 2006 | A1 |
20060265080 | Mcminn | Nov 2006 | A1 |
20070010890 | Collazo | Jan 2007 | A1 |
20070123992 | Sanford | May 2007 | A1 |
20070129808 | Justin et al. | Jun 2007 | A1 |
20070135924 | Verhoogen | Jun 2007 | A1 |
20070135926 | Walker | Jun 2007 | A1 |
20070185581 | Akizuki et al. | Aug 2007 | A1 |
20070198022 | Lang et al. | Aug 2007 | A1 |
20070233269 | Steines et al. | Oct 2007 | A1 |
20070234819 | Amirouche et al. | Oct 2007 | A1 |
20070239165 | Amirouche | Oct 2007 | A1 |
20080021566 | Peters et al. | Jan 2008 | A1 |
20080051908 | Angibaud et al. | Feb 2008 | A1 |
20080058947 | Earl et al. | Mar 2008 | A1 |
20080091271 | Bonitati et al. | Apr 2008 | A1 |
20080091272 | Aram et al. | Apr 2008 | A1 |
20080091273 | Hazebrouck | Apr 2008 | A1 |
20080103603 | Hlntermann | May 2008 | A1 |
20080114462 | Guidera et al. | May 2008 | A1 |
20080119938 | Oh | May 2008 | A1 |
20080119940 | Otto et al. | May 2008 | A1 |
20080140212 | Metzger et al. | Jun 2008 | A1 |
20080161918 | Fankhauser et al. | Jul 2008 | A1 |
20080167722 | Metzger et al. | Jul 2008 | A1 |
20080215156 | Duggal et al. | Sep 2008 | A1 |
20080243258 | Sancheti | Oct 2008 | A1 |
20080262624 | White et al. | Oct 2008 | A1 |
20080281426 | Fitz et al. | Nov 2008 | A1 |
20080288080 | Sancheti | Nov 2008 | A1 |
20080300689 | Mc Kinnon et al. | Dec 2008 | A1 |
20080300690 | Burstein et al. | Dec 2008 | A1 |
20090005708 | Johanson et al. | Jan 2009 | A1 |
20090036992 | Tsakonas | Feb 2009 | A1 |
20090043395 | Hotokebuchi et al. | Feb 2009 | A1 |
20090062806 | Scott et al. | Mar 2009 | A1 |
20090082873 | Hazebrouck et al. | Mar 2009 | A1 |
20090088862 | Thomas et al. | Apr 2009 | A1 |
20090125114 | May et al. | May 2009 | A1 |
20090149963 | Sekel | Jun 2009 | A1 |
20090149964 | May et al. | Jun 2009 | A1 |
20090204221 | Walker | Aug 2009 | A1 |
20090204222 | Burstein et al. | Aug 2009 | A1 |
20090210066 | Jasty | Aug 2009 | A1 |
20090222103 | Fitz et al. | Sep 2009 | A1 |
20090259314 | Linder-ganz et al. | Oct 2009 | A1 |
20090264894 | Wasielewski | Oct 2009 | A1 |
20090265011 | Mandell | Oct 2009 | A1 |
20090265013 | Mandell | Oct 2009 | A1 |
20090028731 | Fisher et al. | Nov 2009 | A1 |
20090306786 | Samuelson | Dec 2009 | A1 |
20090306787 | Crabtree et al. | Dec 2009 | A1 |
20090319047 | Walker | Dec 2009 | A1 |
20090319048 | Shah et al. | Dec 2009 | A1 |
20090319049 | Shah et al. | Dec 2009 | A1 |
20090326663 | Dun | Dec 2009 | A1 |
20090326665 | Wyss et al. | Dec 2009 | A1 |
20090326666 | Wyss et al. | Dec 2009 | A1 |
20090326668 | Dun | Dec 2009 | A1 |
20100010494 | Quirno | Jan 2010 | A1 |
20100016976 | Siebel | Jan 2010 | A1 |
20100016977 | Masini | Jan 2010 | A1 |
20100016978 | Williams et al. | Jan 2010 | A1 |
20100016979 | Wyss et al. | Jan 2010 | A1 |
20100036499 | Pinskerova | Feb 2010 | A1 |
20100036500 | Heldreth et al. | Feb 2010 | A1 |
20100063594 | Hazebrouck et al. | Mar 2010 | A1 |
20100063595 | Dietz | Mar 2010 | A1 |
20100076563 | Otto et al. | Mar 2010 | A1 |
20100082111 | Thomas | Apr 2010 | A1 |
20100100011 | Roche | Apr 2010 | A1 |
20100100189 | Metzger | Apr 2010 | A1 |
20100100191 | May et al. | Apr 2010 | A1 |
20100125339 | Earl et al. | May 2010 | A1 |
20100152858 | Lu et al. | Jun 2010 | A1 |
20100191298 | Earl et al. | Jul 2010 | A1 |
20100191341 | Byrd | Jul 2010 | A1 |
20100198275 | Chana et al. | Aug 2010 | A1 |
20100222890 | Barnett et al. | Sep 2010 | A1 |
20100249660 | Sherman et al. | Sep 2010 | A1 |
20100249789 | Rock et al. | Sep 2010 | A1 |
20100262253 | Cipolletti et al. | Oct 2010 | A1 |
20100286788 | Komistek | Nov 2010 | A1 |
20100292804 | Samuelson | Nov 2010 | A1 |
20100305708 | Lang | Dec 2010 | A1 |
20100329530 | Lang et al. | Dec 2010 | A1 |
20110022179 | Andriacchi et al. | Jan 2011 | A1 |
20110029091 | Bojarski et al. | Feb 2011 | A1 |
20110040387 | Ries et al. | Feb 2011 | A1 |
20110082558 | Kim et al. | Apr 2011 | A1 |
20110082559 | Hartdegen et al. | Apr 2011 | A1 |
20110087332 | Bojarski et al. | Apr 2011 | A1 |
20110098824 | Jukes et al. | Apr 2011 | A1 |
20110100011 | Staffend | May 2011 | A1 |
20110125278 | Bercovy et al. | May 2011 | A1 |
20110144760 | Wong et al. | Jun 2011 | A1 |
20110153026 | Heggendorn et al. | Jun 2011 | A1 |
20110190898 | Lenz et al. | Aug 2011 | A1 |
20110202139 | Metzger et al. | Aug 2011 | A1 |
20110251695 | Lenz et al. | Oct 2011 | A1 |
20120022658 | Wentorf | Jan 2012 | A1 |
20120022659 | Wentorf | Jan 2012 | A1 |
20120022660 | Wentorf | Jan 2012 | A1 |
20120035735 | Sanford et al. | Feb 2012 | A1 |
20120035737 | Sanford | Feb 2012 | A1 |
20120095563 | Sanford et al. | Apr 2012 | A1 |
20120101585 | Parisi et al. | Apr 2012 | A1 |
20120158152 | Claypool et al. | Jun 2012 | A1 |
20120179069 | Amirouche | Jul 2012 | A1 |
20120185054 | Maloney et al. | Jul 2012 | A1 |
20120185055 | Maloney et al. | Jul 2012 | A1 |
20120232429 | Fischer et al. | Sep 2012 | A1 |
20120290088 | Amirouche et al. | Nov 2012 | A1 |
20120296437 | Wyss et al. | Nov 2012 | A1 |
20120310246 | Belcher et al. | Dec 2012 | A1 |
20120310361 | Zubok et al. | Dec 2012 | A1 |
20120323335 | Parisi et al. | Dec 2012 | A1 |
20120323336 | Parisi et al. | Dec 2012 | A1 |
20130013076 | Fisher et al. | Jan 2013 | A1 |
20130024001 | Wentorf et al. | Jan 2013 | A1 |
20130079671 | Stein et al. | Mar 2013 | A1 |
20130096567 | Fisher et al. | Apr 2013 | A1 |
20130102929 | Haight et al. | Apr 2013 | A1 |
20130103038 | Fischer et al. | Apr 2013 | A1 |
20130131816 | Parisi et al. | May 2013 | A1 |
20130131817 | Parisi et al. | May 2013 | A1 |
20130131818 | Parisi et al. | May 2013 | A1 |
20130131819 | Parisi | May 2013 | A1 |
20130131820 | Wentorf et al. | May 2013 | A1 |
20130017301 | Irwin | Jul 2013 | A1 |
20130226305 | Donno et al. | Aug 2013 | A1 |
20130253378 | Claypool et al. | Sep 2013 | A1 |
20130261504 | Claypool et al. | Oct 2013 | A1 |
20130261757 | Claypool et al. | Oct 2013 | A1 |
20130261758 | Claypool et al. | Oct 2013 | A1 |
20130345820 | Maloney et al. | Dec 2013 | A1 |
20140025175 | Wentorf et al. | Jan 2014 | A1 |
20140025176 | Wentorf | Jan 2014 | A1 |
20140025177 | Wentorf et al. | Jan 2014 | A1 |
20140052268 | Sanford et al. | Feb 2014 | A1 |
20140052269 | Claypool et al. | Feb 2014 | A1 |
20140156015 | Parisi et al. | Jun 2014 | A1 |
20140163687 | Parisi et al. | Jun 2014 | A1 |
20140249641 | Wentorf et al. | Sep 2014 | A1 |
20140257505 | Parisi et al. | Sep 2014 | A1 |
20140257506 | Sanford et al. | Sep 2014 | A1 |
20140296859 | Claypool et al. | Oct 2014 | A1 |
20150005890 | Parisi et al. | Jan 2015 | A1 |
20150025644 | Heggendorn et al. | Jan 2015 | A1 |
20150066150 | Dai et al. | Mar 2015 | A1 |
20150088140 | Toler et al. | Mar 2015 | A1 |
20150190243 | Claypool et al. | Jul 2015 | A1 |
20150282936 | Parisi et al. | Oct 2015 | A1 |
20150320564 | Parisi et al. | Nov 2015 | A1 |
20150359642 | Claypool et al. | Dec 2015 | A1 |
20160030053 | Yager et al. | Feb 2016 | A1 |
20160038294 | Parisi et al. | Feb 2016 | A1 |
20160045322 | Parisi et al. | Feb 2016 | A1 |
20160135959 | Sanford et al. | May 2016 | A1 |
20160158019 | Grey et al. | Jun 2016 | A1 |
20160184107 | Parisi et al. | Jun 2016 | A1 |
20160287397 | Wentorf | Oct 2016 | A1 |
20160324647 | Claypool et al. | Nov 2016 | A1 |
20170079801 | Drury et al. | Mar 2017 | A1 |
20170143324 | Toler et al. | May 2017 | A1 |
20170156736 | Claypool et al. | Jun 2017 | A1 |
20170231773 | Lu | Aug 2017 | A1 |
20170266011 | Wentorf et al. | Sep 2017 | A1 |
20170281354 | Soffiatti et al. | Oct 2017 | A1 |
20180000601 | Sanford et al. | Jan 2018 | A1 |
20180000602 | Wentorf et al. | Jan 2018 | A1 |
20180000612 | Claypool et al. | Jan 2018 | A1 |
20180021143 | Parisi et al. | Jan 2018 | A1 |
20180021144 | Parisi et al. | Jan 2018 | A1 |
20180085225 | Wentorf et al. | Mar 2018 | A1 |
20180161166 | Dai et al. | Jun 2018 | A1 |
20180256346 | Byrd et al. | Sep 2018 | A1 |
20180325684 | Croll | Nov 2018 | A1 |
20190142594 | Yager | May 2019 | A1 |
20190209333 | Drury et al. | Jul 2019 | A1 |
20190328535 | Drury et al. | Oct 2019 | A1 |
20190350718 | Parisi et al. | Nov 2019 | A1 |
20200069433 | Croll | Mar 2020 | A1 |
20200113702 | Sanford et al. | Apr 2020 | A1 |
20200146830 | Dai et al. | May 2020 | A1 |
20200237518 | Byrd et al. | Jul 2020 | A1 |
20210022875 | Drury et al. | Jan 2021 | A1 |
Number | Date | Country |
---|---|---|
2011343440 | Apr 2014 | AU |
2011286306 | Oct 2014 | AU |
2190029 | Nov 1995 | CA |
2856070 | Jul 2016 | CA |
687584 | Jan 1997 | CH |
1087506 | Jun 1994 | CN |
1174498 | Feb 1998 | CN |
1179709 | Apr 1998 | CN |
1440262 | Sep 2003 | CN |
1549695 | Nov 2004 | CN |
2768715 | Apr 2006 | CN |
1780594 | May 2006 | CN |
1874738 | Dec 2006 | CN |
101214175 | Jul 2008 | CN |
101222886 | Jul 2008 | CN |
101288597 | Oct 2008 | CN |
101347359 | Jan 2009 | CN |
201175391 | Jan 2009 | CN |
101361684 | Feb 2009 | CN |
101401750 | Apr 2009 | CN |
101426453 | May 2009 | CN |
101522136 | Sep 2009 | CN |
101646392 | Feb 2010 | CN |
101658446 | Mar 2010 | CN |
101683289 | Mar 2010 | CN |
101711701 | May 2010 | CN |
101795643 | Aug 2010 | CN |
101835441 | Sep 2010 | CN |
102018584 | Apr 2011 | CN |
102048594 | May 2011 | CN |
102058446 | May 2011 | CN |
102058448 | May 2011 | CN |
102917670 | Feb 2013 | CN |
103118634 | May 2013 | CN |
103118635 | May 2013 | CN |
103118636 | May 2013 | CN |
103370025 | Oct 2013 | CN |
103379880 | Oct 2013 | CN |
103732186 | Apr 2014 | CN |
104039273 | Sep 2014 | CN |
104066402 | Sep 2014 | CN |
104093380 | Oct 2014 | CN |
104135969 | Nov 2014 | CN |
104203160 | Dec 2014 | CN |
104321263 | Jan 2015 | CN |
104379094 | Feb 2015 | CN |
104736105 | Jun 2015 | CN |
105055052 | Nov 2015 | CN |
105167889 | Dec 2015 | CN |
103118634 | Aug 2016 | CN |
103118636 | Aug 2016 | CN |
104093380 | Aug 2016 | CN |
103370025 | Nov 2016 | CN |
106073949 | Nov 2016 | CN |
106214292 | Dec 2016 | CN |
108135701 | Jun 2018 | CN |
106073949 | Dec 2018 | CN |
109310504 | Feb 2019 | CN |
110022798 | Jul 2019 | CN |
110402123 | Nov 2019 | CN |
110636818 | Dec 2019 | CN |
0021421 | Jan 1981 | EP |
0327495 | Aug 1989 | EP |
340919 | Nov 1989 | EP |
0340919 | Nov 1989 | EP |
0372811 | Jun 1990 | EP |
0306744 | Apr 1992 | EP |
0495340 | Jul 1992 | EP |
0636353 | Feb 1995 | EP |
0672397 | Sep 1995 | EP |
0552950 | Sep 1996 | EP |
0536457 | Jan 1997 | EP |
0642328 | Dec 1998 | EP |
0592750 | Jan 1999 | EP |
0903125 | Mar 1999 | EP |
0956836 | Nov 1999 | EP |
0956836 | Nov 1999 | EP |
1025818 | Aug 2000 | EP |
1097679 | May 2001 | EP |
0709074 | Dec 2002 | EP |
1327424 | Jul 2003 | EP |
1378216 | Jan 2004 | EP |
1477143 | Nov 2004 | EP |
1568336 | Aug 2005 | EP |
1719478 | Nov 2006 | EP |
1722721 | Nov 2006 | EP |
1354571 | Jun 2007 | EP |
1396240 | Apr 2008 | EP |
1604623 | Jun 2008 | EP |
1996122 | Dec 2008 | EP |
0927009 | Jan 2009 | EP |
2011455 | Jan 2009 | EP |
1696835 | Feb 2009 | EP |
1132063 | Sep 2009 | EP |
1591082 | Sep 2009 | EP |
2140838 | Jan 2010 | EP |
2140839 | Jan 2010 | EP |
2143403 | Jan 2010 | EP |
2237177 | Oct 2010 | EP |
1555962 | Feb 2011 | EP |
2319460 | May 2011 | EP |
2324799 | May 2011 | EP |
2335654 | Jun 2011 | EP |
2347733 | Jul 2011 | EP |
0689808 | Sep 2012 | EP |
2595573 | May 2013 | EP |
2782525 | Oct 2014 | EP |
2830543 | Feb 2015 | EP |
2830544 | Feb 2015 | EP |
2830544 | Sep 2016 | EP |
2918235 | Jan 2017 | EP |
3143964 | Mar 2017 | EP |
2595574 | May 2017 | EP |
3111894 | Dec 2018 | EP |
2728782 | Jul 1996 | FR |
2736819 | Jan 1997 | FR |
2747914 | Oct 1997 | FR |
2778332 | Nov 1999 | FR |
2788964 | Aug 2000 | FR |
2824260 | Nov 2002 | FR |
2852819 | Oct 2004 | FR |
2926719 | Jul 2009 | FR |
225347 | Dec 1924 | GB |
2253147 | Sep 1992 | GB |
2345446 | Jul 2000 | GB |
7145DELNP2014 | Apr 2015 | IN |
61247449 | Nov 1986 | JP |
62270153 | Nov 1987 | JP |
06203576 | Jul 1994 | JP |
09289998 | Nov 1997 | JP |
09511668 | Nov 1997 | JP |
2000000255 | Jan 2000 | JP |
2000245758 | Sep 2000 | JP |
2003516183 | May 2003 | JP |
2004166802 | Jun 2004 | JP |
2004254811 | Sep 2004 | JP |
3734270 | Jan 2006 | JP |
2007054488 | Mar 2007 | JP |
2007509709 | Apr 2007 | JP |
2007222616 | Sep 2007 | JP |
2009082713 | Apr 2009 | JP |
2009245619 | Oct 2009 | JP |
2010022827 | Feb 2010 | JP |
2010188051 | Sep 2010 | JP |
2010240406 | Oct 2010 | JP |
2010259808 | Nov 2010 | JP |
2011092738 | May 2011 | JP |
2012500667 | Jan 2012 | JP |
2012531265 | Dec 2012 | JP |
2015512307 | Apr 2013 | JP |
2013535276 | Sep 2013 | JP |
2013536005 | Sep 2013 | JP |
2013536006 | Sep 2013 | JP |
2013536007 | Sep 2013 | JP |
2014505517 | Mar 2014 | JP |
2014508554 | Apr 2014 | JP |
2014522292 | Sep 2014 | JP |
2014239900 | Dec 2014 | JP |
2015502203 | Jan 2015 | JP |
2015504333 | Feb 2015 | JP |
2015504759 | Feb 2015 | JP |
2015513966 | May 2015 | JP |
2015231566 | Dec 2015 | JP |
2016028729 | Mar 2016 | JP |
5980341 | Aug 2016 | JP |
2016195841 | Nov 2016 | JP |
2017221732 | Dec 2017 | JP |
WO-9305729 | Apr 1993 | WO |
WO-9409725 | May 1994 | WO |
WO-9514444 | Jun 1995 | WO |
WO-9514446 | Jun 1995 | WO |
WO-9530389 | Nov 1995 | WO |
WO-9535074 | Dec 1995 | WO |
WO-9934755 | Jul 1999 | WO |
WO-0141680 | Jun 2001 | WO |
WO-200141680 | Jun 2001 | WO |
WO-03099106 | Dec 2003 | WO |
WO-2004058108 | Jul 2004 | WO |
WO-2005037147 | Apr 2005 | WO |
WO-2005051240 | Jun 2005 | WO |
WO-2005122967 | Dec 2005 | WO |
WO-2006058057 | Jun 2006 | WO |
WO-2006092167 | Sep 2006 | WO |
WO-2007108804 | Sep 2007 | WO |
WO-2007109641 | Sep 2007 | WO |
WO-2007119173 | Oct 2007 | WO |
WO-2009029631 | Mar 2009 | WO |
WO-2009088235 | Jul 2009 | WO |
WO-2009088236 | Jul 2009 | WO |
WO-2009088238 | Jul 2009 | WO |
WO-2009105495 | Aug 2009 | WO |
WO-2010001010 | Jan 2010 | WO |
WO-2010008803 | Jan 2010 | WO |
WO-2010011590 | Jan 2010 | WO |
WO-2010022272 | Feb 2010 | WO |
WO-2010023062 | Mar 2010 | WO |
WO-2010045537 | Apr 2010 | WO |
WO-2010075365 | Jul 2010 | WO |
WO-2011043955 | Apr 2011 | WO |
WO-2011063123 | May 2011 | WO |
WO-2011071979 | Jun 2011 | WO |
WO-2011072235 | Jun 2011 | WO |
WO-2011110865 | Sep 2011 | WO |
WO-2012004580 | Jan 2012 | WO |
WO-2012018563 | Feb 2012 | WO |
WO-2012018564 | Feb 2012 | WO |
WO-2012018565 | Feb 2012 | WO |
WO-2012018566 | Feb 2012 | WO |
WO-2012018567 | Feb 2012 | WO |
WO-2012020460 | Feb 2012 | WO |
WO-2012082628 | Jun 2012 | WO |
WO-2012083280 | Jun 2012 | WO |
WO-2012112698 | Aug 2012 | WO |
WO-2012173706 | Dec 2012 | WO |
WO-2013003433 | Jan 2013 | WO |
WO-2013013094 | Jan 2013 | WO |
WO-201 3074145 | May 2013 | WO |
WO-2013074142 | May 2013 | WO |
WO-2013074143 | May 2013 | WO |
WO-2013074144 | May 2013 | WO |
WO-2013077919 | May 2013 | WO |
WO-2013115849 | Aug 2013 | WO |
WO-201 3148954 | Oct 2013 | WO |
WO-2013148960 | Oct 2013 | WO |
WO-2017053196 | Mar 2017 | WO |
WO-2018165442 | Sep 2018 | WO |
WO-2018208612 | Nov 2018 | WO |
Entry |
---|
“U.S. Appl. No. 13/087,610, Non Final Office Action dated Feb. 26, 2013”, 7 pgs. |
“U.S. Appl. No. 13/087,610, Notice of Allowance dated Jun. 28, 2013”, 6 pgs. |
“U.S. Appl. No. 13/087,610, Notice of Allowance dated Oct. 8, 2013”, 7 pgs. |
“U.S. Appl. No. 13/087,610, Response filed May 24, 2013 to Non Final Office Action dated Feb. 26, 2013”, 15 pgs. |
“U.S. Appl. No. 13/189,324, Examiner Interview Summary dated Jan. 13, 2014”, 4 pgs. |
“U.S. Appl. No. 13/189,324, Final Office Action dated Jul. 16, 2013”, 19 pgs. |
“U.S. Appl. No. 13/189,324, Non Final Office Action dated Dec. 11, 2012”, 19 pgs. |
“U.S. Appl. No. 13/189,324, Notice of Allowance dated Feb. 20, 2014”, 8 pgs. |
“U.S. Appl. No. 13/189,324, PTO Response to 312 Amendment dated May 29, 2014”, 2 pgs. |
“U.S. Appl. No. 13/189,324, Response filed Jan. 15, 14 to Final Office Action dated Jul. 16, 2013”, 23 pgs. |
“U.S. Appl. No. 13/189,324, Response filed Jun. 10, 2013 to Non Final Office Action dated Dec. 11, 2012”, 24 pgs. |
“U.S. Appl. No. 13/189,328, Non Final Office Action dated Mar. 19, 2013”, 10 pgs. |
“U.S. Appl. No. 13/189,328, Notice of Allowance dated Oct. 8, 2013”, 12 pgs. |
“U.S. Appl. No. 13/189,328, PTO Response to 312 Amendment dated Dec. 13, 2013”, 2 pgs. |
“U.S. Appl. No. 13/189,328, Response filed Jan. 10, 2013 to Restriction Requirement dated Dec. 10, 2012”, 9 pgs. |
“U.S. Appl. No. 13/189,328, Response filed Jul. 18, 2013 to Non Final Office Action dated Mar. 19, 2013”, 16 pgs. |
“U.S. Appl. No. 13/189,328, Restriction Requirement dated Dec. 10, 2012”, 6 pgs. |
“U.S. Appl. No. 13/189,336, Notice of Allowance dated Sep. 13, 2013”, 30 pgs. |
“U.S. Appl. No. 13/189,336, PTO Response to 312 Amendment dated Nov. 25, 2013”, 2 pgs. |
“U.S. Appl. No. 13/189,336, Response filed Apr. 15, 2013 to Restriction Requirement dated Jan. 30, 2013”, 21 pgs. |
“U.S. Appl. No. 13/189,336, Response filed Jul. 17, 2013 to Restriction Requirement dated Jun. 17, 2013”, 20 pgs. |
“U.S. Appl. No. 13/189,336, Restriction Requirement dated Jan. 30, 2013”, 5 pgs. |
“U.S. Appl. No. 13/189,336, Restriction Requirement dated Jun. 17, 2013”, 6 pgs. |
“U.S. Appl. No. 13/189,338, Notice of Allowance dated Sep. 23, 2013”, 23 pgs. |
“U.S. Appl. No. 13/189,338, Response filed Apr. 15, 13 to Restriction Requirement dated Feb. 14, 2013”, 18 pgs. |
“U.S. Appl. No. 13/189,338, Response filed Jul. 17, 2013 to Restriction Requirement dated Jun. 17, 2013”, 16 pgs. |
“U.S. Appl. No. 13/189,338, Restriction Requirement dated Feb. 14, 2013”, 5 pgs. |
“U.S. Appl. No. 13/189,338, Restriction Requirement dated Jun. 17, 2013”, 6 pgs. |
“U.S. Appl. No. 13/189,339, Notice of Allowance dated Sep. 20, 2013”, 16 pgs. |
“U.S. Appl. No. 13/189,339, Response filed Apr. 15, 13 to Restriction Requirement dated Mar. 6, 2013”, 11 pgs. |
“U.S. Appl. No. 13/189,339, Response filed Jul. 17, 2013 to Restriction Requirement dated Jun. 17, 2013”, 10 pgs. |
“U.S. Appl. No. 13/189,339, Restriction Requirement dated Mar. 6, 2013”, 6 pgs. |
“U.S. Appl. No. 13/189,339, Restriction Requirement dated Jun. 17, 2013”, 7 pgs. |
“U.S. Appl. No. 13/229,103, Applicant Interview Summary dated Sep. 23, 2013”, 2 pgs. |
“U.S. Appl. No. 13/229,103, Examiner Interview Summary dated Sep. 13, 2013”, 3 pgs. |
“U.S. Appl. No. 13/229,103, Non Final Office Action dated Apr. 1, 2013”, 18 pgs. |
“U.S. Appl. No. 13/229,103, Notice of Allowance dated Sep. 18, 2013”, 9 pgs. |
“U.S. Appl. No. 13/229,103, Response filed Jul. 1, 2013 to Non Final Office Action dated Apr. 1, 2013”, 19 pgs. |
“U.S. Appl. No. 13/229,103, Supplemental Notice of Allowability dated Oct. 18, 2013”, 2 pgs. |
“U.S. Appl. No. 13/459,037, Final Office Action dated Sep. 23, 2013”, 9 pgs. |
“U.S. Appl. No. 13/459,037, Non Final Office Action dated Apr. 23, 2013”, 10 pgs. |
“U.S. Appl. No. 13/459,037, Notice of Allowance dated Jun. 13, 2014”, 9 pgs. |
“U.S. Appl. No. 13/459,037, Preliminary Amendment filed Apr. 27, 2012”, 3 pgs. |
“U.S. Appl. No. 13/459,037, Response filed Mar. 21, 2014 to Final Office Action dated Sep. 23, 2013”, 15 pgs. |
“U.S. Appl. No. 13/459,037, Response filed Mar. 28, 2013 to Restriction Requirement dated Feb. 26, 2013”, 9 pgs. |
“U.S. Appl. No. 13/459,037, Response filed Jul. 23, 2013 to Non Final Office Action dated Apr. 23, 2013”, 19 pgs. |
“U.S. Appl. No. 13/459,037, Restriction Requirement dated Feb. 26, 2013”, 6 pgs. |
“U.S. Appl. No. 13/459,041, Non Final Office Action dated Jan. 15, 2014”, 16 pgs. |
“U.S. Appl. No. 13/459,041, Non Final Office Action dated Sep. 9, 2014”, 14 pgs. |
“U.S. Appl. No. 13/459,041, Notice of Allowance dated Apr. 2, 2015”, 10 pgs. |
“U.S. Appl. No. 13/459,041, Preliminary Amendment dated Apr. 27, 2012”, 7 pgs. |
“U.S. Appl. No. 13/459,041, PTO Response to Rule 312 Communication dated Jun. 9, 2015”, 2 pgs. |
“U.S. Appl. No. 13/459,041, Response filed May 15, 2014 to Non-Final Office Action dated Jan. 15, 2014”, 24 pgs. |
“U.S. Appl. No. 13/459,041, Response filed Sep. 23, 2013 to Restriction Requirement dated Jul. 25, 2013”, 18 pgs. |
“U.S. Appl. No. 13/459,041, Response filed Dec. 9, 2014 to Non-Final Office Action dated Sep. 9, 2014”, 23 pgs. |
“U.S. Appl. No. 13/459,041, Restriction Requirement dated Jul. 25, 2013”, 9 pgs. |
“U.S. Appl. No. 13/459,048, Non Final Office Action dated Jul. 11, 2013”, 6 pgs. |
“U.S. Appl. No. 13/459,048, Notice of Allowance dated Nov. 26, 2013”, 10 pgs. |
“U.S. Appl. No. 13/459,048, Preliminary Amendment filed Apr. 27, 2012”, 7 pgs. |
“U.S. Appl. No. 13/459,048, Response filed Nov. 11, 2013 to Non-Final Office Action dated Jul. 11, 2013”, 16 pgs. |
“U.S. Appl. No. 13/459,056, Examiner Interview Summary dated Dec. 26, 2013”, 3 pgs. |
“U.S. Appl. No. 13/459,056, Non Final Office Action dated Jul. 25, 2013”, 11 pgs. |
“U.S. Appl. No. 13/459,056, Notice of Allowance dated Feb. 20, 2014”, 5 pgs. |
“U.S. Appl. No. 13/459,056, Preliminary Amendment filed Apr. 27, 2012”, 7 pgs. |
“U.S. Appl. No. 13/459,056, PTO Response to Rule 312 Communication dated May 22, 2014”, 2 pgs. |
“U.S. Appl. No. 13/459,056, Response filed Jan. 24, 2014 to Non-Final office Action dated Jul. 25, 2013”, 27 pgs. |
“U.S. Appl. No. 13/459,056, Response filed Apr. 8, 2013 to Restriction Requirement dated Mar. 6, 2013”, 15 pgs. |
“U.S. Appl. No. 13/459,056, Restriction Requirement dated Mar. 6, 2013”, 6 pgs. |
“U.S. Appl. No. 13/593,339, Non Final Office Action dated Oct. 4, 2013”, 7 pgs. |
“U.S. Appl. No. 13/593,339, Notice of Allowance dated Feb. 14, 2014”, 9 pgs. |
“U.S. Appl. No. 13/593,339, Preliminary Amendment filed Aug. 23, 2012”, 6 pgs. |
“U.S. Appl. No. 13/593,339, Response filed Jan. 31, 2014 to Non-Final Office Action dated Oct. 4, 2013”, 19 pgs. |
“U.S. Appl. No. 13/593,339, Response filed Aug. 30, 2013 to Restriction Requirement dated Aug. 1, 2013”, 14 pgs. |
“U.S. Appl. No. 13/593,339, Restriction Requirement dated Aug. 1, 2013”, 5 pgs. |
“U.S. Appl. No. 13/593,339, Supplemental Notice of Allowability dated Mar. 31, 2014”, 2 pgs. |
“U.S. Appl. No. 13/594,543, Corrected Notice of Allowance dated Mar. 16, 2016”, 2 pgs. |
“U.S. Appl. No. 13/594,543, Examiner Interview Summary dated Jan. 22, 2016”, 3 pgs. |
“U.S. Appl. No. 13/594,543, Final Office Action dated Jul. 17, 2014”, 12 pgs. |
“U.S. Appl. No. 13/594,543, Final Office Action dated Nov. 20, 2015”, 28 pgs. |
“U.S. Appl. No. 13/594,543, Non Final Office Action dated Jun. 19, 2015”, 30 pgs. |
“U.S. Appl. No. 13/594,543, Non Final Office Action dated Dec. 26, 2013”, 15 pgs. |
“U.S. Appl. No. 13/594,543, Non-Final Office Action dated Jan. 9, 2015”, 23 pgs. |
“U.S. Appl. No. 13/594,543, Notice of Allowance dated Mar. 1, 2016”, 9 pgs. |
“U.S. Appl. No. 13/594,543, Preliminary Amendment filed Aug. 24, 2012”, 4 pgs. |
“U.S. Appl. No. 13/594,543, Response filed Feb. 8, 2016 to Final Office Action dated Nov. 20, 2015”, 17 pgs. |
“U.S. Appl. No. 13/594,543, Response filed Apr. 7, 2015 to Non-Final Office Action dated Jan. 9, 2015”, 27 pgs. |
“U.S. Appl. No. 13/594,543, Response filed May 7, 2014 to Non-Final office Action dated Dec. 26, 2013”, 17 pgs. |
“U.S. Appl. No. 13/594,543, Response filed Sep. 21, 2015 to Non-Final Office Action dated Jun. 19, 2015”, 25 pgs. |
“U.S. Appl. No. 13/594,543, Response filed Oct. 11, 2013 to Restriction Requirement dated Sep. 12, 2013”, 8 pgs. |
“U.S. Appl. No. 13/594,543, Response filed Dec. 17, 2014 to Final Office Action dated Jul. 17, 2014”, 15 pgs. |
“U.S. Appl. No. 13/594,543, Restriction Requirement dated Sep. 12, 2013”, 5 pgs. |
“U.S. Appl. No. 13/819,116, Advisory Action dated Jan. 5, 2016”, 3 pgs. |
“U.S. Appl. No. 13/819,116, Corrected Notice of Allowance dated Oct. 21, 2016”, 2 pgs. |
“U.S. Appl. No. 13/819,116, Examiner Interview Summary dated Apr. 18, 2016”, 11 pgs. |
“U.S. Appl. No. 13/819,116, Final Office Action dated Jul. 26, 2016”, 6 pgs. |
“U.S. Appl. No. 13/819,116, Final Office Action dated Oct. 21, 2015”, 15 pgs. |
“U.S. Appl. No. 13/819,116, Non Final Office Action dated Feb. 17, 2016”, 15 pgs. |
“U.S. Appl. No. 13/819,116, Non Final Office Action dated Jun. 2, 2015”, 14 pgs. |
“U.S. Appl. No. 13/819,116, Notice of Allowance dated Sep. 29, 2016”, 5 pgs. |
“U.S. Appl. No. 13/819,116, Preliminary Amendment filed Feb. 26, 2013”, 8 pgs. |
“U.S. Appl. No. 13/819,116, Response filed Mar. 27, 2015 to Restriction Requirement dated Feb. 12, 2015”, 11 pgs. |
“U.S. Appl. No. 13/819,116, Response filed Apr. 29, 2016 to Non Final Office Action dated Feb. 17, 2016”, 17 pgs. |
“U.S. Appl. No. 13/819,116, Response filed Jul. 16, 2015 to Non Final Office Action dated Jun. 2, 2015”, 22 pgs. |
“U.S. Appl. No. 13/819,116, Response filed Sep. 14, 2016 Final Office Action dated Jul. 26, 2016”, 10 pgs. |
“U.S. Appl. No. 13/819,116, Response filed Dec. 15, 2015 to Final Office Action dated Oct. 21, 2015”, 16 pgs. |
“U.S. Appl. No. 13/819,116, Restriction Requirement dated Feb. 12, 2015”, 7 pgs. |
“U.S. Appl. No. 13/836,586, Express Abandonment filed May 30, 2014”, 1 pg. |
“U.S. Appl. No. 13/836,665, Examiner Interview Summary dated Jul. 17, 2014”, 4 pgs. |
“U.S. Appl. No. 13/836,665, Final Office Action dated Jul. 25, 2014”, 25 pgs. |
“U.S. Appl. No. 13/836,665, Non Final Office Action dated Jan. 30, 2014”, 21 pgs. |
“U.S. Appl. No. 13/836,665, Notice of Allowance dated Jun. 9, 2015”, 10 pgs. |
“U.S. Appl. No. 13/836,665, Response filed Jan. 23, 2015 to Final Office Action dated Jul. 25, 2014”, 25 pgs. |
“U.S. Appl. No. 13/836,665, Response filed May 30, 2014 to Non-Final Office Action dated Jan. 30, 2014”, 21 pgs. |
“U.S. Appl. No. 13/837,294, Final Office Action dated Apr. 25, 2016”, 7 pgs. |
“U.S. Appl. No. 13/837,294, Final Office Action dated Jun. 2, 2016”, 7 pgs. |
“U.S. Appl. No. 13/837,294, Non Final Office Action dated Dec. 10, 2015”, 8 pgs. |
“U.S. Appl. No. 13/837,294, Notice of Allowance dated Aug. 25, 2016”, 5 pgs. |
“U.S. Appl. No. 13/837,294, Response filed Mar. 4, 2016 to Non Final Office Action dated Dec. 10, 2015”, 16 pgs. |
“U.S. Appl. No. 13/837,294, Response filed Aug. 3, 2016 to Final Office Action dated Jun. 2, 2016”, 7 pgs. |
“U.S. Appl. No. 13/837,294, Response filed Oct. 12, 2015 to Restriction Requirement dated Aug. 24, 2015”, 9 pgs. |
“U.S. Appl. No. 13/837,294, Restriction Requirement dated Aug. 24, 2015”, 6 pgs. |
“U.S. Appl. No. 13/837,774, Examiner Interview Summary dated Jul. 22, 2014”, 4 pgs. |
“U.S. Appl. No. 13/837,774, Final Office Action dated Mar. 17, 2016”, 14 pgs. |
“U.S. Appl. No. 13/837,774, Final Office Action dated Jul. 28, 2014”, 17 pgs. |
“U.S. Appl. No. 13/837,774, Non Final Office Action dated Feb. 10, 2014”, 33 pgs. |
“U.S. Appl. No. 13/837,774, Non Final Office Action dated Sep. 18, 2015”, 16 pgs. |
“U.S. Appl. No. 13/837,774, Response filed Jan. 28, 2015 to Final Office Action dated Jul. 28, 2014”, 16 pgs. |
“U.S. Appl. No. 13/837,774, Response filed Jun. 10, 2014 to Non-Final Office Action dated Feb. 20, 2014”, 29 pgs. |
“U.S. Appl. No. 13/837,774, Response filed Jul. 7, 2015 to Restriction Requirement dated May 20, 2015”, 10 pgs. |
“U.S. Appl. No. 13/837,774, Response filed Dec. 16, 2015 to Non Final Office Action dated Sep. 18, 2015”, 17 pgs. |
“U.S. Appl. No. 13/837,774, Restriction Requirement dated May 20, 2015”, 6 pgs. |
“U.S. Appl. No. 14/034,076, Appeal Brief Filed Apr. 18, 2016”, 21 pgs. |
“U.S. Appl. No. 14/034,076, Final Office Action dated Dec. 21, 2015”, 11 pgs. |
“U.S. Appl. No. 14/034,076, Non Final Office Action dated Jun. 24, 2015”, 11 pgs. |
“U.S. Appl. No. 14/034,076, Notice of Allowance dated Oct. 28, 2016”, 7 pgs. |
“U.S. Appl. No. 14/034,076, Response filed Nov. 16, 2015 to Non Final Office Action dated Jun. 24, 2015”, 13 pgs. |
“U.S. Appl. No. 14/034,937, Appeal Brief Filed Sep. 9, 2015”, 41 pgs. |
“U.S. Appl. No. 14/034,937, Appeal Decision mailed May 30, 2017”, 34 pgs. |
“U.S. Appl. No. 14/034,937, Final Office Action dated Jun. 5, 2015”, 22 pgs. |
“U.S. Appl. No. 14/034,937, Non Final Office Action dated Jan. 2, 2015”, 21 pgs. |
“U.S. Appl. No. 14/034,937, Notice of Allowance dated Aug. 30, 2017”, 14 pgs. |
“U.S. Appl. No. 14/034,937, Preliminary Amendment filed Sep. 24, 2013”, 3 pgs. |
“U.S. Appl. No. 14/034,937, PTO Response to Rule 312 Communication dated Oct. 10, 2017”, 2 pgs. |
“U.S. Appl. No. 14/034,937, Response filed Mar. 30, 2015 to Non-Final Office Action”, 24 pgs. |
“U.S. Appl. No. 14/034,937, Response filed Oct. 27, 2014 to Restriction Requirement dated Sep. 11, 2014”, 12 pgs. |
“U.S. Appl. No. 14/034,937, Restriction Requirement dated Sep. 11, 2014”, 6 pgs. |
“U.S. Appl. No. 14/034,937, Supplemental Preliminary Amendment filed Oct. 24, 2013”, 11 pgs. |
“U.S. Appl. No. 14/034,944, Non Final Office Action dated Mar. 3, 2015”, 16 pgs. |
“U.S. Appl. No. 14/034,944, Notice of Allowance dated Aug. 28, 2015”, 7 pgs. |
“U.S. Appl. No. 14/034,944, Preliminary Amendment filed Sep. 24, 2013”, 3 pgs. |
“U.S. Appl. No. 14/034,944, Response filed Jun. 23, 2015 to Non Final Office Action dated Mar. 3, 2015”, 15 pgs. |
“U.S. Appl. No. 14/034,944, Response filed Dec. 15, 2014 to Restriction Requirement dated Oct. 14, 2014”, 12 pgs. |
“U.S. Appl. No. 14/034,944, Restriction Requirement dated Oct. 14, 2014”, 6 pgs. |
“U.S. Appl. No. 14/034,944, Supplemental Preliminary Amendment filed Oct. 24, 2013”, 11 pgs. |
“U.S. Appl. No. 14/034,954, Advisory Action dated Aug. 25, 2015”, 3 pgs. |
“U.S. Appl. No. 14/034,954, Final Office Action dated Jun. 1, 2015”, 26 pgs. |
“U.S. Appl. No. 14/034,954, Non Final Office Action dated Dec. 19, 2014”, 25 pgs. |
“U.S. Appl. No. 14/034,954, Notice of Allowance dated Nov. 20, 2015”, 11 pgs. |
“U.S. Appl. No. 14/034,954, Preliminary Amendment filed Sep. 24, 2013”, 3 pgs. |
“U.S. Appl. No. 14/034,954, Response filed Mar. 17, 2015 to Non Final Office Action dated Dec. 19, 2014”, 21 pgs. |
“U.S. Appl. No. 14/034,954, Response filed Aug. 3, 2015 to Final Office Action dated Jun. 1, 2015”, 19 pgs. |
“U.S. Appl. No. 14/034,954, Response filed Aug. 31, 2015 to Advisory Action dated Aug. 25, 2015”, 21 pgs. |
“U.S. Appl. No. 14/034,954, Response filed Oct. 27, 2014 to Restriction Requirement dated Aug. 25, 2014”, 11 pgs. |
“U.S. Appl. No. 14/034,954, Restriction Requirement dated Aug. 25, 2014”, 7 pgs. |
“U.S. Appl. No. 14/034,954, Supplemental Preliminary Amendment filed Oct. 25, 2013”, 8 pgs. |
“U.S. Appl. No. 14/034,963, Final Office Action dated Apr. 13, 2015”, 22 pgs. |
“U.S. Appl. No. 14/034,963, Final Office Action dated Oct. 13, 2015”, 11 pgs. |
“U.S. Appl. No. 14/034,963, Non Final Office Action dated Jul. 1, 2015”, 15 pgs. |
“U.S. Appl. No. 14/034,963, Non Final Office Action dated Nov. 21, 2014”, 19 pgs. |
“U.S. Appl. No. 14/034,963, Notice of Allowance dated Dec. 18, 2015”, 5 pgs. |
“U.S. Appl. No. 14/034,963, Preliminary Amendment filed Sep. 24, 2013”, 3 pgs. |
“U.S. Appl. No. 14/034,963, Response filed Mar. 20, 2015 to Non-Final Office Action dated Nov. 21, 2014”, 20 pgs. |
“U.S. Appl. No. 14/034,963, Response filed Jun. 19, 2015 to Final Office Action dated Apr. 13, 2015”, 17 pgs. |
“U.S. Appl. No. 14/034,963, Response filed Sep. 30, 2015 to Non Final Office Action dated Jul. 1, 2015”, 14 pgs. |
“U.S. Appl. No. 14/034,963, Response filed Nov. 20, 2015 to Final Office Action dated Oct. 13, 2015”, 12 pgs. |
“U.S. Appl. No. 14/063,032, Non Final Office Action dated Jun. 20, 2014”, 6 pgs. |
“U.S. Appl. No. 14/063,032, Notice of Allowance dated Dec. 19, 2014”, 6 pgs. |
“U.S. Appl. No. 14/063,032, Preliminary Amendment filed Oct. 25,2013”, 3 pgs. |
“U.S. Appl. No. 14/063,032, Response filed Oct. 20, 2014 to Non-Final Office Action dated Jun. 20, 2014”, 9 pgs. |
“U.S. Appl. No. 14/063,593, Advisory Action dated Aug. 19, 2016”, 3 pgs. |
“U.S. Appl. No. 14/063,593, Final Office Action dated Jun. 9, 2016”, 10 pgs. |
“U.S. Appl. No. 14/063,593, Non Final Office Action dated Jan. 25, 2016”, 9 pgs. |
“U.S. Appl. No. 14/063,593, Non Final Office Action dated Nov. 30, 2016”, 12 pgs. |
“U.S. Appl. No. 14/063,593, Notice of Allowance dated May 2, 2017”, 5 pgs. |
“U.S. Appl. No. 14/063,593, Notice of Allowance dated May 25, 2017”, 5 pgs. |
“U.S. Appl. No. 14/063,593, Preliminary Amendment filed Oct. 25, 2013”, 3 pgs. |
“U.S. Appl. No. 14/063,593, Response filed Jan. 4, 2016 to Restriction Requirement dated Nov. 6, 2015”, 6 pgs. |
“U.S. Appl. No. 14/063,593, Response filed Feb. 24, 2017 to Non Final Office Action dated Nov. 30, 2016”, 17 pgs. |
“U.S. Appl. No. 14/063,593, Response filed Apr. 20, 2016 to Non Final Office Action dated Jan. 25, 2016”, 17 pgs. |
“U.S. Appl. No. 14/063,593, Response filed Aug. 11, 2016 to Final Office Action dated Jun. 9, 2016”, 10 pgs. |
“U.S. Appl. No. 14/063,593, Restriction Requirement dated Nov. 6, 2015”, 6 pgs. |
“U.S. Appl. No. 14/181,033, Non Final Office Action dated May 1, 2015”, 5 pgs. |
“U.S. Appl. No. 14/181,033, Notice of Allowance dated Jul. 17, 2015”, 10 pgs. |
“U.S. Appl. No. 14/181,033, Response filed Jun. 22, 2015 to Non-Final Office Action dated May 1, 2015”, 11 pgs. |
“U.S. Appl. No. 14/278,805, Notice of Allowance dated Dec. 1, 2015”, 8 pgs. |
“U.S. Appl. No. 14/278,805, Supplemental Notice of Allowability dated Jan. 21, 2016”, 2 pgs. |
“U.S. Appl. No. 14/284,028, Non Final Office Action dated Jul. 7, 2015”, 17 pgs. |
“U.S. Appl. No. 14/284,028, Notice of Allowance dated Nov. 6, 2015”, 5 pgs. |
“U.S. Appl. No. 14/284,028, Response filed Oct. 6, 2015 to Non Final Office Action dated Jul. 7, 2015”, 15 pgs. |
“U.S. Appl. No. 14/284,028, Supplemental Notice of Allowability dated Feb. 26, 2016”, 5 pgs. |
“U.S. Appl. No. 14/284,028, Supplemental Preliminary Amendment filed Jul. 8, 2014”, 13 pgs. |
“U.S. Appl. No. 14/284,144, Final Office Action dated Aug. 7, 2015”, 13 pgs. |
“U.S. Appl. No. 14/284,144, Non Final Office Action dated Mar. 25, 2015”, 26 pgs. |
“U.S. Appl. No. 14/284,144, Notice of Allowance dated Oct. 29, 2015”, 8 pgs. |
“U.S. Appl. No. 14/284,144, Preliminary Amendment filed May 21, 2014”, 3 pgs. |
“U.S. Appl. No. 14/284,144, Response filed Oct. 9, 2015 to Final Office Action dated Aug. 7, 2015”, 13 pgs. |
“U.S. Appl. No. 14/284,144, Response filed Jun. 23, 2015 to Non Final Office Action dated Mar. 25, 2015”, 22 pgs. |
“U.S. Appl. No. 14/284,144, Supplemental Preliminary Amendment filed Jul. 3, 2014”, 10 pgs. |
“U.S. Appl. No. 14/304,009, Notice of Allowance dated Nov. 16, 2016”, 7 pgs. |
“U.S. Appl. No. 14/304,009, Preliminary Amendment Filed Jul. 31, 2014”, 7 pgs. |
“U.S. Appl. No. 14/490,153, Final Office Action dated Apr. 15, 2015”, 18 pgs. |
“U.S. Appl. No. 14/490,153, Non Final Office Action dated Nov. 12, 2014”, 9 pgs. |
“U.S. Appl. No. 14/490,153, Notice of Allowance dated Aug. 14, 2015”, 10 pgs. |
“U.S. Appl. No. 14/490,153, Preliminary Amendment filed Sep. 18, 2014”, 3 pgs. |
“U.S. Appl. No. 14/490,153, Response filed Feb. 18, 2015 to Non-Final Office Action dated Nov. 12, 2014”, 14 pgs. |
“U.S. Appl. No. 14/490,153, Response filed Jul. 7, 2015 to Final Office Action dated Apr. 15, 2015”, 14 pgs. |
“U.S. Appl. No. 14/660,217, Corrected Notice of Allowance dated May 26, 2016”, 3 pgs. |
“U.S. Appl. No. 14/660,217, Non Final Office Action dated Dec. 17, 2015”, 8 pgs. |
“U.S. Appl. No. 14/660,217, Notice of Allowance dated Apr. 26, 2016”, 5 pgs. |
“U.S. Appl. No. 14/660,217, Preliminary Amendment filed Mar. 18, 2015”, 9 pgs. |
“U.S. Appl. No. 14/660,217, Response filed Mar. 23, 2016 to Non Final Office Action dated Dec. 17, 2015”, 14 pgs. |
“U.S. Appl. No. 14/740,690, Non Final Office Action dated Dec. 7, 2016”, 19 pgs. |
“U.S. Appl. No. 14/740,690, Notice of Allowability dated Aug. 29, 2017”, 2 pgs. |
“U.S. Appl. No. 14/740,690, Notice of Allowance dated Jun. 13, 2017”, 9 pgs. |
“U.S. Appl. No. 14/740,690, Response filed Mar. 3, 2017 to Non Final Office Action dated Dec. 7, 2016”, 14 pgs. |
“U.S. Appl. No. 14/791,952, Corrected Notice of Allowance dated Jul. 21, 2017”, 2 pgs. |
“U.S. Appl. No. 14/791,952, Final Office Action dated Mar. 31, 2017”, 8 pgs. |
“U.S. Appl. No. 14/791,952, Final Office Action dated Sep. 1, 2016”, 17 pgs. |
“U.S. Appl. No. 14/791,952, Non Final Office Action dated Apr. 21, 2016”, 12 pgs. |
“U.S. Appl. No. 14/791,952, Non Final Office Action dated Dec. 29, 2016”, 12 pgs. |
“U.S. Appl. No. 14/791,952, Notice of Allowance dated May 30, 2017”, 7 pgs. |
“U.S. Appl. No. 14/791,952, Preliminary Amendment filed Jul. 7, 2015”, 7 pgs. |
“U.S. Appl. No. 14/791,952, Response filed Mar. 20, 2017 to Non Final Office Action dated Dec. 29, 2016”, 12 pgs. |
“U.S. Appl. No. 14/791,952, Response filed May 17, 2017—to Final Office Action dated Mar. 31, 2017”, 10 pgs. |
“U.S. Appl. No. 14/791,952, Response filed Jul. 15, 2016 to Non Final Office Action dated Apr. 21, 2016”, 18 pgs. |
“U.S. Appl. No. 14/791,952, Response filed Nov. 21, 2016 to Final Office Action dated Sep. 1, 2016”, 15 pgs. |
“U.S. Appl. No. 14/833,385, Examiner Interview Summary dated Dec. 27, 2017”, 3 pgs. |
“U.S. Appl. No. 14/833,385, Final Office Action dated Nov. 13, 2017”, 9 pgs. |
“U.S. Appl. No. 14/833,385, Non Final Office Action dated Jun. 19, 2017”, 10 pgs. |
“U.S. Appl. No. 14/833,385, Preliminary Amendment filed Aug. 25, 2015”, 6 pgs. |
“U.S. Appl. No. 14/833,385, Response filed May 12, 2017 to Restriction Requirement dated Mar. 17, 2017”, 8 pgs. |
“U.S. Appl. No. 14/833,385, Response filed Sep. 18, 2017 to Non Final Office Action dated Jun. 19, 2017”, 14 pgs. |
“U.S. Appl. No. 14/833,385, Restriction Requirement dated Mar. 17, 2017”, 6 pgs. |
“U.S. Appl. No. 14/918,721, Final Office Action dated Oct. 20, 2016”, 5 pgs. |
“U.S. Appl. No. 14/918,721, Non Final Office Action dated Jun. 16, 2016”, 6 pgs. |
“U.S. Appl. No. 14/918,721, Notice of Allowance dated Feb. 1, 2017”, 9 pgs. |
“U.S. Appl. No. 14/918,721, Preliminary Amendment filed Oct. 23, 2015”, 8 pgs. |
“U.S. Appl. No. 14/918,721, PTO Response to Rule 312 Communication dated Mar. 17, 2017”, 2 pgs. |
“U.S. Appl. No. 14/918,721, Response filed Sep. 12, 2016 to Non Final Office Action dated Jun. 16, 2016”, 12 pgs. |
“U.S. Appl. No. 14/918,721, Response filed Dec. 13, 2016 to Final Office Action dated Oct. 20, 2016”, 9 pgs. |
“U.S. Appl. No. 14/926,281, Non Final Office Action dated Jun. 21, 2017”, 17 pgs. |
“U.S. Appl. No. 14/926,281, Notice of Allowance dated Nov. 16, 2017”, 9 pgs. |
“U.S. Appl. No. 14/926,281, Preliminary Amendment filed Oct. 30, 2015”, 8 pgs. |
“U.S. Appl. No. 14/926,281, Response filed Sep. 18, 2017 to Non Final Office Action dated Jun. 21, 2017”, 11 pgs. |
“U.S. Appl. No. 15/003,091, Preliminary Amendment filed Jan. 22, 2016”, 12 pgs. |
“U.S. Appl. No. 15/003,091, Non Final Office Action dated Jun. 20, 2017”, 14 pgs. |
“U.S. Appl. No. 15/003,091, Notice of Allowance dated Nov. 6, 2017”, 8 pgs. |
“U.S. Appl. No. 15/003,091, PTO Response to Rule 312 Communication dated Jan. 23, 2018”, 2 pgs. |
“U.S. Appl. No. 15/003,091, Response filed Sep. 20, 2017 to Non Final Office Action dated Jun. 20, 2017”, 17 pgs. |
“U.S. Appl. No. 15/045,799, Non Final Office Action dated Nov. 1, 2016”, 8 pgs. |
“U.S. Appl. No. 15/045,799, Notice of Allowance dated Mar. 10, 2017”, 10 pgs. |
“U.S. Appl. No. 15/045,799, Preliminary Amendment filed Feb. 2018, 16”, 9 pgs. |
“U.S. Appl. No. 15/045,799, PTO Response to Rule 312 Communication dated Apr. 18, 2017”, 2 pgs. |
“U.S. Appl. No. 15/045,799, Response filed Feb. 1, 2017 to Non Final Office Action dated Nov. 1, 2016”, 15 pgs. |
“U.S. Appl. No. 15/062,252, Preliminary Amendment filed Mar. 9, 2016”, 8 pgs. |
“U.S. Appl. No. 15/062,262, Non Final Office Action dated Jul. 22, 2016”, 12 pgs. |
“U.S. Appl. No. 15/062,262, Notice of Allowance dated Jan. 31, 2017”, 5 pgs. |
“U.S. Appl. No. 15/062,262, PTO Response to Rule 312 Communication dated Mar. 7, 2017”, 2 pgs. |
“U.S. Appl. No. 15/062,262, Response filed Oct. 24, 2016 to Non Final Office Action dated Jul. 22, 2016”, 13 pgs. |
“U.S. Appl. No. 15/177,734, Non Final Office Action dated Feb. 10, 2017”, 21 pgs. |
“U.S. Appl. No. 15/177,734, Notice of Allowance dated May 17, 2017”, 7 pgs. |
“U.S. Appl. No. 15/177,734, Preliminary Amendment filed Jun. 22, 2016”, 8 pgs. |
“U.S. Appl. No. 15/177,734, Response filed Apr. 19, 2017 to Non Final Office Action dated Feb. 10, 2017”, 22 pgs. |
“U.S. Appl. No. 15/211,812, Non Final Office Action dated Jan. 27, 2017”, 5 pgs. |
“U.S. Appl. No. 15/211,812, Notice of Allowance dated May 31, 2017”, 5 pgs. |
“U.S. Appl. No. 15/211,812, Preliminary Amendment filed Sep. 8, 2016”, 8 pgs. |
“U.S. Appl. No. 15/211,812, Response filed Apr. 19, 2017 to Non Final Office Action dated Jan. 27, 2017”, 9 pgs. |
“U.S. Appl. No. 15/267,793, Non Final Office Action dated Jun. 14, 2018”, 12 pgs. |
“U.S. Appl. No. 15/267,793, Notice of Allowability dated Jan. 17, 2019”, 2 pgs. |
“U.S. Appl. No. 15/267,793, Notice of Allowance dated Dec. 21, 2018”, 5 pgs. |
“U.S. Appl. No. 15/267,793, Response Filed Apr. 11, 2018 to Restriction Requirement dated Feb. 16, 2018”, 8 pgs. |
“U.S. Appl. No. 15/267,793, Response filed Aug. 22, 2018 Non Final Office Action dated Jun. 14, 2018”, 16 pgs. |
“U.S. Appl. No. 15/267,793, Restriction Requirement dated Feb. 16, 2018”, 7 pgs. |
“U.S. Appl. No. 15/424,328, Non Final Office Action dated Jun. 23, 2017”, 5 pgs. |
“U.S. Appl. No. 15/424,328, Notice of Allowance dated Oct. 16, 2017”, 6 pgs. |
“U.S. Appl. No. 15/424,328, Preliminary Amendment filed Feb. 28, 2017”, 10 pgs. |
“U.S. Appl. No. 15/424,328, Response filed Sep. 20, 2017 to Non Final Office Action dated Jun. 23, 2017”, 9 pgs. |
“U.S. Appl. No. 15/435,620, Final Office Action dated Dec. 15, 2017”, 9 pgs. |
“U.S. Appl. No. 15/435,620, Non Final Office Action dated Jul. 26, 2017”, 10 pgs. |
“U.S. Appl. No. 15/435,620, Notice of Allowance dated Mar. 13, 2018”, 5 pgs. |
“U.S. Appl. No. 15/435,620, Preliminary Amendment filed Mar. 20, 2017”, 7 pgs. |
“U.S. Appl. No. 15/435,620, Response filed Feb. 12, 2018 to Final Office Action dated Dec. 15, 2017”, 9 pgs. |
“U.S. Appl. No. 15/435,620, Response filed Oct. 25, 2017 to Non Final Office Action dated Jul. 26, 2017”, 13 pgs. |
“U.S. Appl. No. 15/616,561, Non Final Office Action mailed Aug. 9, 2018”, 8 pgs. |
“U.S. Appl. No. 15/616,561, Notice of Allowability dated Feb. 12, 2019”, 2 pgs. |
“U.S. Appl. No. 15/616,561, Notice of Allowance dated Dec. 10, 2018”, 7 pgs. |
“U.S. Appl. No. 15/616,561, Preliminary Amendment filed Jun. 8, 2017”, 7 pgs. |
“U.S. Appl. No. 15/616,561, Response filed Nov. 8, 2018 to Non Final Office Action dated Aug. 9, 2018”, 11 pgs. |
“U.S. Appl. No. 15/703,678, Non Final Office Action mailed Apr. 8, 2019”, 11 pgs. |
“U.S. Appl. No. 15/703,678, Notice of Allowance dated Sep. 17, 2019”, 7 pgs. |
“U.S. Appl. No. 15/703,678, Preliminary Amendment filed Sep. 28, 2017”, 9 pgs. |
“U.S. Appl. No. 15/703,678, Response Filed Jan. 3, 2019 to Restriction Requirement dated Nov. 5, 2018”, 8 pgs. |
“U.S. Appl. No. 15/703,678, Response filed Jul. 3, 2019 to Non-Final Office Action dated Apr. 8, 2019”, 20 pgs. |
“U.S. Appl. No. 15/703,678, Restriction Requirement dated Nov. 5, 2018”, 6 pgs. |
“U.S. Appl. No. 15/703,692, Corrected Notice of Allowability dated Jul. 8, 2019”, 2 pgs. |
“U.S. Appl. No. 15/703,692, Non Final Office Action dated Jan. 14, 2019”, 11 pgs. |
“U.S. Appl. No. 15/703,692, Notice of Allowance dated May 7, 2019”, 5 pgs. |
“U.S. Appl. No. 15/703,692, Preliminary Amendment filed Sep. 28, 2017”, 9 pgs. |
“U.S. Appl. No. 15/703,692, Response filed Apr. 4, 2019 to Non Final Office Action dated Jan. 14, 2019”, 11 pgs. |
“U.S. Appl. No. 15/703,698, Corrected Notice of Allowability dated Dec. 18, 2018”, 2 pgs. |
“U.S. Appl. No. 15/703,698, Non Final Office Action dated Apr. 6, 2018”, 7 pgs. |
“U.S. Appl. No. 15/703,698, Notice of Allowance dated Sep. 12, 2018”, 5 pgs. |
“U.S. Appl. No. 15/703,698, Preliminary Amendment filed Sep. 28, 2017”, 8 pgs. |
“U.S. Appl. No. 15/703,698, Response filed Jul. 6, 2018 to Non Final Office Action dated Apr. 6, 2018”, 10 pgs. |
“U.S. Appl. No. 15/703,713, Non Final Office Action dated Mar. 27, 2018”, 29 pgs. |
“U.S. Appl. No. 15/703,713, Notice of Allowance dated Sep. 25, 2018”, 11 pgs. |
“U.S. Appl. No. 15/703,713, Response Filed Jun. 15, 2018 to Non-Final Office Action dated Mar. 27, 2018”, 16 pgs. |
“U.S. Appl. No. 15/703,713, Preliminary Amendment filed Sep. 28, 2017”, 7 pgs. |
“U.S. Appl. No. 15/720,866, Non Final Office Action dated Sep. 9, 2019”, 12 pgs. |
“U.S. Appl. No. 15/720,866, Response filed Jul. 10, 2019 to Restriction Requirement dated May 14, 2019”, 10 pgs. |
“U.S. Appl. No. 15/720,866, Response filed Nov. 13, 2017 to Non Final Office Action dated Sep. 14, 2017”, 10 pgs. |
“U.S. Appl. No. 15/720,866, Restriction Requirement dated May 14, 2019”, 7 pgs. |
“U.S. Appl. No. 15/720,866, Preliminary Amendment filed Nov. 13, 2017”, 9 pgs. |
“U.S. Appl. No. 15/827,654, Examiner Interview Summary dated Apr. 26, 2019”, 4 pgs. |
“U.S. Appl. No. 15/827,654, Final Office Action dated Feb. 19, 2019”, 19 pgs. |
“U.S. Appl. No. 15/827,654, Non Final Office Action dated Sep. 7, 2018”, 21 pgs. |
“U.S. Appl. No. 15/827,654, Notice of Allowance dated Jul. 8, 2019”, 8 pgs. |
“U.S. Appl. No. 15/827,654, Preliminary Amendment filed Dec. 22, 2017”, 11 pgs. |
“U.S. Appl. No. 15/827,654, Response Filed May 20, 2019 to Final Office Action dated Feb. 19, 2019”, 17 pgs. |
“U.S. Appl. No. 15/827,654, Response filed Jun. 6, 2018 to Restriction Requirement dated Apr. 6, 2018”, 11 pgs. |
“U.S. Appl. No. 15/827,654, Response filed to Non Final Office Action dated Sep. 7, 2018”, 24 pgs. |
“U.S. Appl. No. 15/827,654, Restriction Requirement dated Apr. 6, 2018”, 6 pgs. |
“U.S. Appl. No. 15/915,886, Non Final Office Action dated Aug. 2, 2019”, 9 pgs. |
“U.S. Appl. No. 16/530,423, Preliminary Amendment filed Aug. 28, 2019”, 7 pgs. |
“Australian Application Serial No. 2011286306, First Examiner Report dated Jun. 19, 2013”, 4 pgs. |
“Australian Application Serial No. 2011286306, Response filed Jun. 3, 2014 to First Examiner Report dated Jun. 19, 2013”, 16 pgs. |
“Australian Application Serial No. 2011286307, First Examiner Report dated Oct. 17, 2013”, 2 pgs. |
“Australian Application Serial No. 2011286307, Response filed May 21, 2014 to First Examiner Report dated Oct. 17, 2013”, 16 pgs. |
“Australian Application Serial No. 2011286308, First Examiner Report dated Jun. 21, 2013”, 4 pgs. |
“Australian Application Serial No. 2011286308, Response filed Jun. 6, 2014 First Examiner Report dated Jun. 21, 2013”, 19 pgs. |
“Australian Application Serial No. 2011286309, First Examiner Report dated Jun. 21, 2013”, 3 pgs. |
“Australian Application Serial No. 2011286309, Response filed Jun. 10, 2014 to First Examiner Report dated Jun. 21, 2013”, 4 pgs. |
“Australian Application Serial No. 2011343440, First Examiner Report dated Feb. 17, 2014”, 3 pgs. |
“Australian Application Serial No. 2011343440, Response filed Mar. 21, 2014 to Office Action dated Feb. 17, 2014”, 1 pg. |
“Australian Application Serial No. 2012341026, First Examiner Report dated Jul. 14, 2014”, 2 pgs. |
“Australian Application Serial No. 2012341026, Response filed Nov. 21, 2014 to First Examiner Report dated Jul. 14, 2014”, 1 pg. |
“Australian Application Serial No. 2012341026, Statement of Proposed Amendment filed Jun. 18, 2014”, 25 pgs. |
“Australian Application Serial No. 2012368262, First Examiner Report dated Nov. 2, 2016”, 4 pgs. |
“Australian Application Serial No. 2012368262, Response filed Jan. 17, 2017 to Office Action dated Nov. 2, 2016”, 21 pgs. |
“Australian Application Serial No. 2012368262, Response filed May 15, 2017 to Subsequent Examiners Report dated Mar. 16, 2017”, 2 pgs. |
“Australian Application Serial No. 2012368262, Subsequent Examiners Report dated Mar. 16, 2017”, 3 pgs. |
“Australian Application Serial No. 2013238046, First Examiner Report dated Nov. 26, 2015”, 2 pgs. |
“Australian Application Serial No. 2013238046, Response filed Feb. 2, 2016 to First Examiner Report dated Nov. 26, 2015”, 1 pg. |
“Australian Application Serial No. 2013238054, First Examiner Report dated Oct. 17, 2016”, 4 pgs. |
“Australian Application Serial No. 2013238054, Response filed Jan. 18, 2017 to First Examiner Report dated Oct. 17, 2016”, 9 pgs. |
“Australian Application Serial No. 2014250709, First Examiner Report dated Dec. 21, 2015”, 3 pgs. |
“Australian Application Serial No. 2014250709, Response filed May 4, 2016 to First Examiner Report dated Dec. 21, 2015”, 12 pgs. |
“Australian Application Serial No. 2014250709, Subsequent Examiners Report dated May 31, 2016”, 6 pgs. |
“Australian Application Serial No. 2014250710, First Examiner Report dated Dec. 11, 2015”, 7 pgs. |
“Australian Application Serial No. 2014250710, Response filed Mar. 22, 2016 to First Examiner Report dated Dec. 11, 2015”, 18 pgs. |
“Australian Application Serial No. 2014250710, Response filed May 4, 2016 to Subsequent Examiners Report dated Mar. 23, 2016”, 15 pgs. |
“Australian Application Serial No. 2014250710, Subsequent Examiners Report dated Mar. 23, 2016”, 3 pgs. |
“Australian Application Serial No. 2014250711, First Examiner Report dated Feb. 12, 2016”, 7 pgs. |
“Australian Application Serial No. 2014250711, Response filed Apr. 27, 2016 to First Examiner Report dated Feb. 12, 2016”, 32 pgs. |
“Australian Application Serial No. 2015201511, First Examination Report dated Apr. 18, 2016”, 2 pgs. |
“Australian Application Serial No. 2015201511, Response filed Jun. 30, 2016 to First Examiner Report dated Apr. 18, 2016”, 12 pgs. |
“Australian Application Serial No. 2015238820, First Examination Report dated May 30, 2017”, 3 pgs. |
“Australian Application Serial No. 2015238820, Response filed Jul. 12, 2017 to First Examination Report dated May 30, 2017”, 12 pgs. |
“Australian Application Serial No. 2016225911, First Examiners Report dated Jun. 2, 2017”, 3 pgs. |
“Australian Application Serial No. 2016225911, Response filed Aug. 22, 2017 to First Examiners Report dated Jun. 2, 2017”, 18 pgs. |
“Australian Application Serial No. 2017235987, First Examination Report dated Nov. 1, 2018”, 4 pgs. |
“Australian Application Serial No. 2017251736, First Examiners Report dated Oct. 31, 2017”, 2 pgs. |
“Bi-Cruciate Stabilized Knee System”, Design Rationale, Smith & Nephew Journal, (2006), 20 pgs. |
“Canadian Application Serial No. 2,806,321, Office Action dated Jan. 15, 2018”, 3 pgs. |
“Canadian Application Serial No. 2,806,321, Response filed Jan. 22, 2018 to Office Action dated Jan. 15, 2018”, 7 pgs. |
“Canadian Application Serial No. 2,806,321, Response filed Dec. 6, 2017 to Office Action dated Jun. 15, 2017”, 12 pgs. |
“Canadian Application Serial No. 2,806,325, Office Action dated Mar. 14, 2016”, 4 pgs. |
“Canadian Application Serial No. 2,806,325, Response filed Sep. 14, 2016 to Office Action dated Mar. 14, 2016”, 17 pgs. |
“Canadian Application Serial No. 2,806,326, Examiner's Rule 30(2) Requisition dated Sep. 20, 2018”, 4 pgs. |
“Canadian Application Serial No. 2,806,326, Office Action dated Feb. 8, 2018”, 4 pgs. |
“Canadian Application Serial No. 2,806,326, Office Action dated Jun. 19, 2017”, 3 pgs. |
“Canadian Application Serial No. 2,806,326, Response Filed Mar. 20, 2019 to Examiner's Rule 30(2) Requisition dated Sep. 20, 2018”, 4 pgs. |
“Canadian Application Serial No. 2,806,326, Response filed Jul. 20, 2018 to Office Action dated Feb. 8, 2018”, 12 pgs. |
“Canadian Application Serial No. 2,821,927, Office Action dated Jan. 25, 2018”, 6 pgs. |
“Canadian Application Serial No. 2,821,927, Response filed Jul. 18, 2018 to Office Action dated Jan. 25, 2018”, 10 pgs. |
“Canadian Application Serial No. 2,821,927, Voluntary Amendment dated Jun. 14, 2013”, 7 pgs. |
“Canadian Application Serial No. 2,824,527, Office Action dated Mar. 17, 2014”, 2 pgs. |
“Canadian Application Serial No. 2,824,527, Response filed Sep. 17, 2014 to Office Action dated Mar. 17, 2014”, 14 pgs. |
“Canadian Application Serial No. 2,856,070, Preliminary Amendment filed May 25, 2015”, 27 pgs. |
“Canadian Application Serial No. 2,856,571 Response filed Jan. 22, 2015 to Office Action dated Jul. 22, 2014”, 24 pgs. |
“Canadian Application Serial No. 2,856,571, Office Action dated Jul. 22, 2014”, 2 pgs. |
“Canadian Application Serial No. 2,863,375, Office Action dated Apr. 20, 2018”, 3 pgs. |
“Canadian Application Serial No. 2,863,375, Response filed Oct. 22, 2018 Office Action dated Apr. 20, 2018”, 12 pgs. |
“Canadian Application Serial No. 2,868,825, Office Action dated Dec. 27, 2018”, 3 pgs. |
“Canadian Application Serial No. 2,956,119, Examiner's Rule 30(2) Requisition dated Sep. 27, 2018”, 4 pgs. |
“Canadian Application Serial No. 2,956,119, Office Action dated Jan. 22, 2018”, 3 pgs. |
“Canadian Application Serial No. 2,956,119, Response Filed Mar. 27, 2019 to Examiner's Rule 30(2) Requisition dated Sep. 27, 2018”, 7 pgs. |
“Canadian Application Serial No. 2,989,184, Office Action dated Oct. 1, 2018”, 4 pgs. |
“Canadian Application Serial No. 2,989,184, Response filed Apr. 1, 2019 to Office Action dated Oct. 1, 2018”, 10 pgs. |
“Canadian Application Serial No. 2,806,321, Office Action dated Jun. 15, 2017”, 3 pgs. |
“Chinese Application Serial No. 201180045673.3, Office Action dated Feb. 14, 2016”, (W/English Translation), 17 pgs. |
“Chinese Application Serial No. 201180045673.3, Office Action dated Mar. 29, 2015”, (W/English Translation), 6 pgs. |
“Chinese Application Serial No. 201180045673.3, Office Action dated Aug. 12, 2015”, (W/English Translation), 7 pgs. |
“Chinese Application Serial No. 201180045673.3, Response filed Apr. 19, 2016 to Office Action dated Feb. 14, 2016”, No English Translation, 11 pqs. |
“Chinese Application Serial No. 201180045673.3, Response filed Jun. 19, 2015 to Office Action dated Mar. 29, 2015”, (W/ English translation of claims), 11 pgs. |
“Chinese Application Serial No. 201180045673.3, Response filed Oct. 27, 2015 to Office Action dated Aug. 12, 2015”, (W/ English translation of claims), 9 pgs. |
“Chinese Application Serial No. 201180045681.8, Office Action dated Jan. 22, 2015”, (W/English Translation), 11 pgs. |
“Chinese Application Serial No. 201180045681.8, Response filed May 14, 2015 to Office Action dated Jan. 22, 2015”, W/ English Claims, 17 pgs. |
“Chinese Application Serial No. 201180045683.7, Office Action dated Mar. 9, 2015”, (W/English Translation), 6 pgs. |
“Chinese Application Serial No. 201180045683.7, Response filed Jul. 14, 2015 to Office Action dated Mar. 9, 2015”, (W/ English translation of claims), 30 pgs. |
“Chinese Application Serial No. 201180045689.4, Office Action dated Jan. 5, 2015”, (W/English Translation), 4 pgs. |
“Chinese Application Serial No. 201180045689.4, Office Action dated Feb. 2, 2016”, w/English Translation, 11 pgs. |
“Chinese Application Serial No. 201180045689.4, Office Action dated Aug. 5, 2015”, (W/English Translation), 11 pgs. |
“Chinese Application Serial No. 201180045689.4, Response filed Apr. 7, 2016 to Office Action dated Feb. 2, 2016”, No English Translation, 8 pgs. |
“Chinese Application Serial No. 201180045689.4, Response filed May 1, 2015 to Office Action dated Jan. 5, 2015”, W/ English Claims, 13 pgs. |
“Chinese Application Serial No. 201180045689.4,Response filed Oct. 21, 2015 to Office Action dated Aug. 5, 2015”, No English Claims. |
“Chinese Application Serial No. 201180067430.X, Office Action dated Aug. 28, 2014”, (W/English Translation), 8 pgs. |
“Chinese Application Serial No. 201180067430.X, Response filed Jan. 4, 2015 to Office Action dated Sep. 26, 2014”, (W/ English Translation), 14 pgs. |
“Chinese Application Serial No. 201180067757.7, Office Action dated Mar. 2, 2015”, (W/English Translation), 18 pgs. |
“Chinese Application Serial No. 201180067757.7, Office Action dated Jun. 1, 2016”, (W/English Translation), 10 pgs. |
“Chinese Application Serial No. 201180067757.7, Office Action dated Nov. 16, 2015”, (W/English Translation), 17 pgs. |
“Chinese Application Serial No. 201180067757.7, Response filed Jun. 27, 2016 to Office Action dated Nov. 16, 2015”, (W/ English Translation of Claims), 12 pgs. |
“Chinese Application Serial No. 201180067757.7, Response filed Jul. 10, 2015 to Office Action dated Mar. 2, 2015”, (W/ English Translation), 13 pgs. |
“Chinese Application Serial No. 201180067757.7, Response filed Aug. 11, 2016 to Office Action dated Jun. 1, 2016”, (W/ English Translation Of Claims), 9 pgs. |
“Chinese Application Serial No. 201180067757.7, Voluntary Amendment dated Feb. 14, 2014”, (W/ English Translation of Claims), 8 pgs. |
“Chinese Application Serial No. 201280067473.2, Office Action dated Feb. 1, 2016”, (W/English Translation), 4 pgs. |
“Chinese Application Serial No. 201280067473.2, Office Action dated May 20, 2015”, (W/English Translation), 15 pgs. |
“Chinese Application Serial No. 201280067473.2, Office Action dated Nov. 20, 2015”, W/English Translation of Claims, 7 pgs. |
“Chinese Application Serial No. 201280067473.2, Response filed Apr. 7, 2016 to Office Action dated Feb. 1, 2016”, (W/ English translation of claims), 11 pgs. |
“Chinese Application Serial No. 201280067473.2, Response filed Sep. 7, 2015 to Office Action dated May 20, 2015”, (W/ English translation of claims), 12 pgs. |
“Chinese Application Serial No. 201280067473.2, Response filed Dec. 4, 2015 to Office Action dated Nov. 20, 2015”, w/English Claims, 11 pgs. |
“Chinese Application Serial No. 201280067481.7, Office Action dated Sep. 30, 2015”, (W/English Translation), 7 pgs. |
“Chinese Application Serial No. 201280071940.9, Office Action dated Jul. 22, 2015”, (W/English Translation), 13 pgs. |
“Chinese Application Serial No. 201280071940.9, Preliminary Amendment filed Mar. 23, 2015”, W/ English Claims, 11 pgs. |
“Chinese Application Serial No. 201380028572.4, Office Action dated Aug. 13, 2015”, (W/English Translation), 16 pgs. |
“Chinese Application Serial No. 201380028683.5, Office Action dated Jun. 27, 2016”, (W/English Translation), 8 pgs. |
“Chinese Application Serial No. 201380028683.5, Office Action dated Nov. 4, 2015”, (W/English Translation), 16 pgs. |
“Chinese Application Serial No. 201380028683.5, Office Action dated Dec. 30, 2016”, (W/English Translation), 4 pgs. |
“Chinese Application Serial No. 201380028683.5, Response filed Feb. 8, 2017 to Office Action dated Dec. 30, 2016”, (W/ English Translation), 13 pgs. |
“Chinese Application Serial No. 201380028683.5, Response filed Mar. 18, 2016 to Office Action dated Nov. 4, 2015”, (W/ English Translation of Claims), 11 pgs. |
“Chinese Application Serial No. 201380028683.5, Response filed Sep. 6, 2016 to Office Action dated Jun. 27, 2016”, (W/ English Translation of Claims), 11 pgs. |
“Chinese Application Serial No. 201510394094.X, Office Action dated May 24, 2017”, (W/English Translation), 11 pgs. |
“Chinese Application Serial No. 201510394094.X, Office Action dated Aug. 30, 2016”, (W/English Translation), 14 pgs. |
“Chinese Application Serial No. 201510394094.X, Office Action dated Nov. 3, 2017”, (W/English Translation), 10 pgs. |
“Chinese Application Serial No. 201510394094.X, Response filed Jan. 16, 2017 to Office Action dated Aug. 30, 2016”, (W/ English Translation of Claims), 11 pgs. |
“Chinese Application Serial No. 201510394094.X, Response filed Jan. 18, 2018 to Office Action dated Nov. 3, 2017”, (W/ English Claims), 10 pgs. |
“Chinese Application Serial No. 201510394094.X, Response filed Jul. 10, 2017 to Office Action dated May 24, 2017”, (W/ English Translation), 10 pgs. |
“Chinese Application Serial No. 201510640436.1, Office Action dated Sep. 28, 2016”, (W/English Translation), 13 pgs. |
“Chinese Application Serial No. 201510640436.1, Response filed Feb. 16, 2017 to Office Action dated Sep. 28, 2016”, (W/ English Translation), 18 pgs. |
“Chinese Application Serial No. 201610634595.5, Office Action dated Apr. 20, 2018”, (W/English Translation), 8 pgs. |
“Chinese Application Serial No. 201610634595.5, Office Action dated Jun. 21, 2017”, w/English Translation, 9 pgs. |
“Chinese Application Serial No. 201610634595.5, Response filed Jun. 4, 2018 to Office Action dated Apr. 20, 2018”, (W/ English Translation of Claims), 8 pgs. |
“Chinese Application Serial No. 201610634595.5, Response filed Nov. 3, 2017 to Office Action dated Jun. 21, 2017”, w/English Claims, 8 pgs. |
“Chinese Application Serial No. 201610685172.6, Office Action dated Apr. 10, 2017”, (W/English Translation), 11 pgs. |
“Chinese Application Serial No. 201610685172.6, Office Action dated Sep. 28, 2017”, (W/English Translation), 9 pgs. |
“Chinese Application Serial No. 201610685172.6, Response filed Dec. 13, 2017 to Office Action dated Sep. 28, 2017”, (W/ English Claims), 13 pgs. |
“Chinese Application Serial No. 201680061268.3, Office Action dated Apr. 24, 2019”, (W/English Translation), 11 pgs. |
“Chinese Application Serial No. 201680061268.3, Response filed Aug. 21, 2019 to Office Action dated Apr. 24, 2019”, (W/ English Claims), 8 pgs. |
“Complete Knee Solution Surgical Technique for the CR-Flex Fixed Bearing Knee”, Zimmer Nexgen, (2003), 22 pgs. |
“European Application Serial No. 11738918.9, Examination Notification Art. 94(3) dated Oct. 23, 2014”, 5 pgs. |
“European Application Serial No. 11738918.9, Preliminary Amendment dated Sep. 24, 2013”, 11 pgs. |
“European Application Serial No. 11738918.9, Response filed Mar. 2, 2015 to Examination Notification Art. 94(3) dated Oct. 23, 2014”, 14 pgs. |
“European Application Serial No. 11738919.7, Examination Notification Art. 94(3) dated Jul. 7, 2014”, 4 pgs. |
“European Application Serial No. 11738919.7, Preliminary Amendment filed Nov. 4, 2013”, 25 pgs. |
“European Application Serial No. 11738919.7, Response filed Nov. 13, 2014 to Examination Notification Art. 94(3) dated Jul. 7, 2014”, 14 pgs. |
“European Application Serial No. 11738920.5, Communication Pursuant to Article 94(3) EPC dated Mar. 15, 2016”, 4 pgs. |
“European Application Serial No. 11738920.5, Preliminary Amendment Sep. 24, 2013”, 9 pgs. |
“European Application Serial No. 11738920.5, Response filed Jul. 25, 2016 to Communication Pursuant to Article 94(3) EPC dated Mar. 15, 2016”, 6 pgs. |
“European Application Serial No. 11738920.5, Response filed Sep. 24, 2013 to Communication pursuant to Rules 161(2) and 162 EPC dated Mar. 15, 2013”, 22 pgs. |
“European Application Serial No. 11758060.5, Communication Pursuant to Article 94(3) EPC dated Jul. 12, 2016”, 3 pgs. |
“European Application Serial No. 11758060.5, Communication Pursuant to Article 94(3) EPC dated Dec. 11, 2015”, 4 pgs. |
“European Application Serial No. 11758060.5, Preliminary Amendment filed Nov. 4, 2013”, 15 pgs. |
“European Application Serial No. 11758060.5, Response filed Apr. 21, 2016 to Communication Pursuant to Article 94(3) EPC dated Dec. 11, 2015”, 16 pgs. |
“European Application Serial No. 11758060.5, Response filed Nov. 15, 2016 to Communication Pursuant to Article 94(3) EPC dated Jul. 12, 2016”, 23 pgs. |
“European Application Serial No. 11802835.6, Communication Pursuant to Article 94(3) EPC dated Dec. 11, 2017”, 4 pgs. |
“European Application Serial No. 11802835.6, Response filed Apr. 23, 2018 to Office Action dated Dec. 11, 2017”, 16 pgs. |
“European Application Serial No. 11808493.8, Communication Pursuant to Article 94(3) EPC dated Dec. 7, 2015”, 4 pgs. |
“European Application Serial No. 11808493.8, Examination Notification Art. 94(3) dated Feb. 20, 2015”, 6 pgs. |
“European Application Serial No. 11808493.8, Response filed Feb. 26, 2014 to Communication pursuant to Rules 161(1) and 162 EPC dated Aug. 16, 2013”, 14 pgs. |
“European Application Serial No. 11808493,8, Response filed Apr. 18, 2016 to Communication Pursuant to Article 94(3) EPC dated Dec. 7, 2015”, 15 pgs. |
“European Application Serial No. 11808493.8, Response filed Jul. 2, 2015 to Examination Notification Art. 94(3) dated Feb. 20, 2015”, 13 pgs. |
“European Application Serial No. 11815029.1, Communication Pursuant to Article 94(3) EPC dated Sep. 29, 2016”, 4 pgs. |
“European Application Serial No. 11815029.1, Extended European Search Report dated Dec. 10, 2013”, 8 pgs. |
“European Application Serial No. 11815029.1, Response filed Apr. 10, 2017 to Communication Pursuant to Article 94(3) EPC dated Sep. 29, 2016”, 22 pgs. |
“European Application Serial No. 11815029.1, Response filed Jul. 21, 2014 Extended European Search Report dated Dec. 10, 2013”, 15 pgs. |
“European Application Serial No. 12718882.9, Communication Pursuant to Article 94(3) EPC dated Dec. 1, 2015”, 11 pgs. |
“European Application Serial No. 12718882.9, Response filed Feb. 10, 2015 to Communication Pursuant to Rules 161(1) and 162 EPC dated Jul. 31, 2014”, 11 pgs. |
“European Application Serial No. 12718882.9, Response filed Apr. 11, 2016 to Communication Pursuant to Article 94(3) EPC dated Dec. 1, 2015”, 12 pgs. |
“European Application Serial No. 12718883.7, Communication Pursuant to Article 94(3) EPC dated Dec. 2, 2015”, 4 pgs. |
“European Application Serial No. 12718883.7, Communication Pursuant to Rules 161(1) and 162 EPC dated Jul. 31, 2014”, 2 pgs. |
“European Application Serial No. 12718883.7, Intention to Grant dated May 20, 2016”, 5 pgs. |
“European Application Serial No. 12718883.7, Response filed Feb. 10, 2015 to Communication Pursuant to Rules 161(1) and 162 EPC dated Jul. 31, 2014”, 16 pgs. |
“European Application Serial No. 12718883.7, Response filed Apr. 12, 2016 to Communication Pursuant to Article 94(3) EPC dated Dec. 2, 2015”, 30 pgs. |
“European Application Serial No. 12719236.7 Response filed Feb. 9, 2015 to Communication Pursuant to Rules 161(1) and 162 EPC dated Jul. 30, 2014”, 10 pgs. |
“European Application Serial No. 12719236.7, Decision to Grant dated Feb. 18, 2016”, 3 pgs. |
“European Application Serial No. 12719236.7, Office Action dated Aug. 27, 2015”, 7 pgs. |
“European Application Serial No. 1270352.9 Response filed Feb. 9, 2015 to Communication Pursuant to Rules 161(1) and 162 EPC dated Jul. 30, 2014”, 10 pgs. |
“European Application Serial No. 12756058.9, Communication Pursuant to Article 94(3) EPC dated Feb. 18, 2019”, 4 pgs. |
“European Application Serial No. 12756058.9, Office Action dated Jan. 17, 2017”, 5 Pgs. |
“European Application Serial No. 12756058.9, Preliminary Amendment filed Apr. 20, 2015”, 12 pgs. |
“European Application Serial No. 12756058.9, Response filed May 26, 2017 to Office Action dated Jan. 17, 2017”, 16 pgs. |
“European Application Serial No. 12756058.9, Response filed Jun. 28, 2019 to Communication Pursuant to Article 94(3) EPC dated Feb. 18, 2019”, 21 pgs. |
“European Application Serial No. 12756869.9 Response filed Feb. 10, 2015 to Communication Pursuant to Rule 161(1) and 162 EPC dated Jul. 31, 2014”, 14 pgs. |
“European Application Serial No. 12756869.9, Examination Notification Art. 94(3) dated Jul. 2, 2015”, 4 pgs. |
“European Application Serial No. 12756869.9, Response filed Nov. 12, 2015 to Examination Notification Art. 94(3) dated Jul. 2, 2015”, 28 pgs. |
“European Application Serial No. 13716636.9, Communication Pursuant to Article 9 4(3) EPC dated Nov. 16, 2015”, 4 pgs. |
“European Application Serial No. 13716636.9, Communication Pursuant to Article 94(3) EPC dated Nov. 17, 2016”, 4 pgs. |
“European Application Serial No. 13716636.9, Communication Pursuant to Article 94(3) EPC dated Jun. 6, 2016”, 5 pgs. |
“European Application Serial No. 13716636.9, Communication pursuant to Rules 161(1) and 162 EPC dated Dec. 12, 2014”, 2 pgs. |
“European Application Serial No. 13716636.9, Response filed Mar. 24, 2016 to Communication Pursuant to Article 94(3) EPC dated Nov. 16, 2015”, 18 pgs. |
“European Application Serial No. 13716636.9, Response filed Mar. 27, 2017 to Communication Pursuant to Article 94(3) EPC dated Nov. 17, 2016”, 15 pgs. |
“European Application Serial No. 13716636.9, Response filed Jun. 22, 2015 to Communication pursuant to Rules 161(1) and 162 EPC dated Dec. 12, 2014”, 10 pgs. |
“European Application Serial No. 13716636.9, Response filed Oct. 17, 2016 to Communication Pursuant to Article 94(3) EPC dated Jun. 6, 2016”, 5 pgs. |
“European Application Serial No. 14190180.1, Extended European Search Report dated Sep. 24, 2015”, 8 pgs. |
“European Application Serial No. 15160934.4, Communication Pursuant to Article 94(3) EPC dated Apr. 26, 2018”, 5 pgs. |
“European Application Serial No. 15160934.4, Extended European Search Report dated Jun. 1, 2016”, 8 pgs. |
“European Application Serial No. 15160934.4, Response filed Aug. 30, 2018 to Communication Pursuant to Article 94(3) EPC dated Apr. 26, 2018”, 63 pgs. |
“European Application Serial No. 15160934.4, Response filed Dec. 21, 2016 to Extended European Search Report dated Jun. 1, 2016”, 5 pgs. |
“European Application Serial No. 15174394.5, Extended European Search Report dated Mar. 21, 2016”, 8 pgs. |
“European Application Serial No. 15174394.5, Response filed Nov. 18, 2016 to Extended European Search Report dated Mar. 21, 2016”, 12 pgs. |
“European Application Serial No. 15191781.2, Communication Pursuant to Article 94(3) EPC dated Jan. 8, 2018”, 4 pgs. |
“European Application Serial No. 15191781.2, Extended European Search Report dated Mar. 1, 2017”, 8 pgs. |
“European Application Serial No. 15191781.2, Response filed May 17, 2018 to Communication Pursuant to Article 94(3) EPC dated Jan. 8, 2018”, 58 pgs. |
“European Application Serial No. 15191781.2, Response filed Sep. 28, 2017 to Extended European Search Report dated Mar. 1, 2017”, 14pgs. |
“European Application Serial No. 16156228.5, Extended European Search Report dated May 11, 2017”, 5 pgs. |
“European Application Serial No. 16183635.8, Extended European Search Report dated Jun. 30, 2017”, 9 pgs. |
“European Application Serial No. 16183635.8, Response filed Mar. 27, 2018 to Extended European Search Report dated Jun. 30, 2017”, 8 pgs. |
“European Application Serial No. 16189084.3, Extended European Search Report dated Oct. 9, 2017”, 9 pgs. |
“European Application Serial No. 16189084.3, Response filed May 10, 2018 to Extended European Search Report dated Oct. 9, 2017”, 20 pgs. |
“European Application Serial No. 16770657.1, Communication Pursuant to Article 94(3) EPC dated May 20, 2019”, 3 pgs. |
“European Application Serial No. 16770657.1, Response filed Nov. 26, 18 to Office Action dated May 14, 2018”, 17 pgs. |
“European Application Serial No. 17157909.7, Extended European Search Report dated Jul. 17, 2018”, 7 pgs. |
“European Application Serial No. 17157909.7, Response Filed Feb. 15, 2019 to Extended European Search Report dated Jul. 17, 2018”, 37 pgs. |
“European Application Serial No. 17163432.2, Extended European Search Report dated May 14, 2018”, 6 pgs. |
“European Application Serial No. 17163440.5, Extended European Search Report dated Jan. 3, 2019”, 16 pgs. |
“European Application Serial No. 17163440.5, Partial European Search Report dated Jul. 23, 2018”, 15 pgs. |
“European Application Serial No. 17163440.5, Response filed Jul. 22, 2019 to Extended European Search Report dated Jan. 3, 2019”, 14 pgs. |
“European Application Serial No. 17168095.2, Extended European Search Report dated Jun. 8, 2018”, 8 pgs. |
“European Application Serial No. 17168095.2, Response Filed Jan. 17, 2019 Extended European Search Report dated Jun. 8, 2018”, 29 pgs. |
“European Application Serial No. 17168308.9, Extended European Search Report dated Jun. 13, 2018”, 8 pgs. |
“European Application Serial No. 17168308.9, Response Filed Jan. 17, 2019 to Extended European Search Report dated Jun. 13, 2018”, 24 pgs. |
“Gender Solutions Natural Knee Flex System: Because Men and Women are Different”, Zimmer, Inc., (2007, 2009), 6 pg. |
“Gender Solutions Natural Knee Flex System: Surgical Technique”, Zimmer, Inc., (2007, 2008, 2009), 36 pgs. |
“Gender Solutions Natural-Knee Flex System”, Zimmer, Inc., (2007, 2009), 6 pgs. |
“Indian Application Serial No. 1544/DELNP/2013, Office Action dated May 21, 2019”, (W/English Translation), 10 pgs. |
“International Application Serial No. PCT/US2011/045077, International Preliminary Report on Patentability dated Jul. 5, 2012”, 23 pgs. |
“International Application Serial No. PCT/US2011/045077, International Search Report and Written Opinion dated Jan. 9, 2012”, 15 pgs. |
“International Application Serial No. PCT/US2011/045078, International Preliminary Report on Patentability dated Feb. 7, 2013”, 11 pgs. |
“International Application Serial No. PCT/US2011/045078, International Search Report and Written Opinion dated Jan. 9, 2012”, 14 pgs. |
“International Application Serial No. PCT/US2011/045080, International Preliminary Report on Patentability dated Feb. 7, 2013”, 13 pgs. |
“International Application Serial No. PCT/US2011/045080, International Search Report dated Jan. 9, 2012”, 7 pgs. |
“International Application Serial No. PCT/US2011/045080, Written Opinion dated Jan. 9, 2012”, 11 pgs. |
“International Application Serial No. PCT/US2011/045082, International Preliminary Report on Patentability dated Feb. 7, 2013”, 11 pgs. |
“International Application Serial No. PCT/US2011/045082, International Search Report dated Jan. 9, 2012”, 5 pgs. |
“International Application Serial No. PCT/US2011/045082, Written Opinion dated Jan. 9, 2012”, 10 pgs. |
“International Application Serial No. PCT/US2011/045083, International Preliminary Report on Patentability dated Feb. 7, 2013”, 8 pgs. |
“International Application Serial No. PCT/US2011/045083, International Search Report dated Dec. 7, 2011”, 2 pgs. |
“International Application Serial No. PCT/US2011/045083, Written Opinion dated Dec. 7, 2011”, 6 pgs. |
“International Application Serial No. PCT/US2011/051021, International Preliminary Report on Patentability dated Mar. 21, 2013”, 8 pgs. |
“International Application Serial No. PCT/US2011/051021, International Search Report dated Nov. 23, 2011”, 12 pgs. |
“International Application Serial No. PCT/US2011/051021, Written Opinion dated Nov. 23, 2011”, 7 pgs. |
“International Application Serial No. PCT/US2011/064435, International Preliminary Report on Patentability dated Jun. 27, 2013”, 9 pgs. |
“International Application Serial No. PCT/US2011/064435, Search Report dated Jun. 21, 2012”, 5 pgs. |
“International Application Serial No. PCT/US2011/064435, Written Opinion dated Jun. 21, 2012”, 7 pgs. |
“International Application Serial No. PCT/US2011/065683, International Preliminary Report on Patentability dated Jun. 27, 2013”, 11 pgs. |
“International Application Serial No. PCT/US2011/065683, International Search Report dated Apr. 24, 2012”, 12 pgs. |
“International Application Serial No. PCT/US2011/065683, Written Opinion dated Apr. 24, 2012”, 10 pgs. |
“International Application Serial No. PCT/US2012/035679, International Preliminary Report on Patentability dated May 30, 2014”, 8 pgs. |
“International Application Serial No. PCT/US2012/035679, International Search Report dated Jun. 8, 2012”, 4 pgs. |
“International Application Serial No. PCT/US2012/035679, Written Opinion dated Jun. 8, 2012”, 7 pgs. |
“International Application Serial No. PCT/US2012/035680, International Preliminary Report on Patentability dated May 30, 2014”, 13 pgs. |
“International Application Serial No. PCT/US2012/035680, Search Report dated Oct. 9, 2012”, 7 pgs. |
“International Application Serial No. PCT/US2012/035680, Written Opinion dated Oct. 9, 2012”, 11 pgs. |
“International Application Serial No. PCT/US2012/035683, International Preliminary Report on Patentability dated May 30, 2014”, 9 pgs. |
“International Application Serial No. PCT/US2012/035683, International Search Report and Written Opinion dated Jun. 5, 2012”, 12 pgs. |
“International Application Serial No. PCT/US2012/035684, International Preliminary Report on Patentability dated May 30, 2014”, 14 pgs. |
“International Application Serial No. PCT/US2012/035684, International Search Report dated Aug. 8, 2012”, 9 pgs. |
“International Application Serial No. PCT/US2012/035684, Written Opinion dated Jun. 8, 2012”, 12 pgs. |
“International Application Serial No. PCT/US2012/052132, International Preliminary Report on Patentability dated Jun. 5, 2014”, 12 pgs. |
“International Application Serial No. PCT/US2012/052132, International Search Report dated Jan. 10, 2013”, 5 pgs. |
“International Application Serial No. PCT/US2012/052132, Invitation to Pay Additional Fees and Partial Search Report dated Nov. 15, 2012”, 7 pgs. |
“International Application Serial No. PCT/US2012/052132, Written Opinion dated Jan. 10, 2013”, 10 pgs. |
“International Application Serial No. PCT/US2012/052340, International Preliminary Report on Patentability dated Aug. 14, 2014”, 8 pgs. |
“International Application Serial No. PCT/US2012/052340, Search Report dated Oct. 12, 2012”, 4 pgs. |
“International Application Serial No. PCT/US2012/052340, Written Opinion dated Oct. 12, 2012”, 6 pgs. |
“International Application Serial No. PCT/US2013/034286, International Preliminary Report on Patentability dated Oct. 9, 2014”, 8 pgs. |
“International Application Serial No. PCT/US2013/034286, International Search Report dated Jun. 25, 2013”, 6 pgs. |
“International Application Serial No. PCT/US2013/034286, Written Opinion dated Jun. 25, 2013”, 6 pgs. |
“International Application Serial No. PCT/US2013/034293, International Preliminary Report on Patentability dated Oct. 9, 2014”, 9 pgs. |
“International Application Serial No. PCT/US2013/034293, International Search Report dated Jun. 25, 2013”, 6 pgs. |
“International Application Serial No. PCT/US2013/034293, Written Opinion dated Jun. 25, 2013”, 7 pgs. |
“International Application Serial No. PCT/US2016/052163, International Preliminary Report on Patentability dated Apr. 5, 2018”, 10 pgs. |
“International Application Serial No. PCT/US2016/052163, International Search Report dated Jan. 20, 2017”, 7 pgs. |
“International Application Serial No. PCT/US2016/052163, Invitation to Pay Add'l Fees and Partial Search Report dated Nov. 7, 2016”, 7 pgs. |
“International Application Serial No. PCT/US2016/052163, Written Opinion dated Jan. 20, 2017”, 8 pgs. |
“International Application Serial No. PCT/US2018/021571, International Preliminary Report on Patentability dated Sep. 19, 2019”, 8 pgs. |
“International Application Serial No. PCT/US2018/021571, International Search Report dated Jun. 7, 2018”, 6 pgs. |
“International Application Serial No. PCT/US2018/021571, Written Opinion dated Jun. 7, 2018”, 6 pgs. |
“Intramedullary Instrumentation Surgical Technique for the NexGen Cruciate Retaining & Legacy Posterior Stabilized Knee”, Zimmer, Inc. Nexgen Complete Knee Solution, 97-5973-102, Rev. 1, (1995, 1997, 1998), 36 pgs. |
“Japanese Application Serial No. 2015-162707, Office Action dated Jun. 28, 2016”, (W/English Translation), 8 pgs. |
“Japanese Application Serial No. 2013-521854, Notice of Reason for Rejection dated Sep. 16, 2014”, (W/ English Translation), 6 pgs. |
“Japanese Application Serial No. 2013-521854, Response filed Dec. 16, 2014 to Notice of Reason for Rejection dated Sep. 16, 2014”, W/ English Claims, 11 pgs. |
“Japanese Application Serial No. 2013-521855, Amendment filed Jul. 22, 2014”, (W/ English Translation), 20 pgs. |
“Japanese Application Serial No. 2013-521855, Office Action dated Mar. 24, 2015”, W/ English Translation, 8 pgs. |
“Japanese Application Serial No. 2013-521856, Notice of Allowance dated Jan. 5, 2016”, w/English Translation, 6 pgs. |
“Japanese Application Serial No. 2013-521856, Office Action dated Sep. 1, 2015”, (W/ English Translation), 5 pgs. |
“Japanese Application Serial No. 2013-521856, Response filed Dec. 1, 2015 to Office Action dated Sep. 1, 2015”, w/English Translation, 9 pgs. |
“Japanese Application Serial No. 2013-521857, Notice of Allowance dated Feb. 9, 2016”, w/English Translation, 6 pgs. |
“Japanese Application Serial No. 2013-521857, Notice of Reasons for Rejection dated Aug. 18, 2015”, (W/ English Translation), 6 pgs. |
“Japanese Application Serial No. 2013-521857, Preliminary Amendment filed May 18, 2014”, (W/ English translation of claims), 9 pgs. |
“Japanese Application Serial No. 2013-521857, Response filed Jan. 25, 2016 to Notice of Reasons for Rejection dated Aug. 18, 2015”, (W/ English Translation), 17 pgs. |
“Japanese Application Serial No. 2013-544655, Office Action dated Mar. 8, 2016”, (W/ English Translation), 8 pgs. |
“Japanese Application Serial No. 2013-544655, Office Action dated Sep. 29, 2015”, (W/ English Translation), 7 pgs. |
“Japanese Application Serial No. 2013-544655, Response filed Jan. 4, 2016 to Office Action dated Sep. 29, 2015”, (English Translation of Claims), 14 pgs. |
“Japanese Application Serial No. 2013-544655, Response filed Jul. 14, 2016 to Office Action dated Mar. 8, 2016”, (w/ English Translation of Claims), 13 pgs. |
“Japanese Application Serial No. 2013-544858, Request for Examination filed Feb. 4, 2014”, (With English Translation), 14 pgs. |
“Japanese Application Serial No. 2014-121515, Notice of Reasons for Rejection dated Jan. 5, 2016”, (W/ English Translation), 9 pgs. |
“Japanese Application Serial No. 2014-121515, Office Action dated Jun. 2, 2015”, (W/ English Translation), 10 pgs. |
“Japanese Application Serial No. 2014-121515, Response filed May 11, 2016 to Notice of Reasons for Rejection dated Jan. 5, 2016”, (W/ English Translation Of Claims), 11 pgs. |
“Japanese Application Serial No. 2014-121515, Response filed Aug. 20, 2015 to Office Action dated Jun. 2, 2015”, (W/ English Translation Of Claims), 6 pgs. |
“Japanese Application Serial No. 2014-542297, Office Action dated May 31, 2016”, (W/ English Translation Of Claims), 6 pgs. |
“Japanese Application Serial No. 2014-542297, Office Action dated Jun. 30, 2015”, (W/ English Translation), 10 pgs. |
“Japanese Application Serial No. 2014-542297, Office Action dated Nov. 24, 2015”, (W/ English Translation), 10 pgs. |
“Japanese Application Serial No. 2014-542297, Response filed Feb. 23, 2016 to Office Action dated Nov. 24, 2015”, (W/ English Translation Of Claims), 15 pgs. |
“Japanese Application Serial No. 2014-542297, Response filed Jun. 8, 2016 to Office Action dated May 31, 2016”, (W/ English Translation Of Claims), 14 pgs. |
“Japanese Application Serial No. 2014-542297, Response filed Sep. 28, 2015 to Office Action dated Jun. 30, 2015”, (W/ English Translation Of Claims), 16 pgs. |
“Japanese Application Serial No. 2014-542301, Office Action dated May 12, 2015”, (W/ English Translation), 6 pgs. |
“Japanese Application Serial No. 2014-542301, Response filed Aug. 10, 2015 to Office Action dated May 12, 2015”, (W/ English translation of claims), 21 pgs. |
“Japanese Application Serial No. 2014-554709, Office Action dated Jul. 5, 2016”, (W/ English Translation), 6 pgs. |
“Japanese Application Serial No. 2014-554709, Preliminary Amendment filed Jul. 29, 2015”, (W/ English translation of claims), 8 pgs. |
“Japanese Application Serial No. 2014-554709, Response filed Dec. 19, 2016 to Office Action dated Jul. 5, 2016”, (W/ English Translation of Claims), 11 pgs. |
“Japanese Application Serial No. 2015-162707, Office Action dated Nov. 29, 2016”, (W/ English Translation), 3 pgs. |
“Japanese Application Serial No. 2015-162707, Response filed Jan. 26, 2017 to Office Action dated Nov. 27, 2016”, (W/ English Translation), 16 pgs. |
“Japanese Application Serial No. 2015-199496, Office Action dated Sep. 6, 2016”, (W/ English Translation), 5 pgs. |
“Japanese Application Serial No. 2015-199496, Response filed Dec. 5, 2016 to Office Action dated Sep. 6, 2016”, (W/ English Translation of Claims), 9 pgs. |
“Japanese Application Serial No. 2015-503563, Office Action dated Dec. 20, 2016”, (W/ English Translation), 10 pgs. |
“Japanese Application Serial No. 2015-503563, Response Filed Mar. 13, 2017 to Office Action dated Dec. 20, 2016”, (W/ English Translation), 9 pgs. |
“Japanese Application Serial No. 2016-145390, Office Action dated Apr. 25, 2017”, (W/ English Translation), 5 pgs. |
“Japanese Application Serial No. 2016-145390, Response filed Jul. 3, 2017 to Office Action dated Apr. 25, 2017”, (W/ English Translation of Claims), 16 pgs. |
“Japanese Application Serial No. 2017-161246, Office Action dated May 15, 2018”, (W/ English Translation), 6 pgs. |
“Legacy Implant Options”, Nexgen Complete Knee Solution, (2002), 8 pgs. |
“LPS-Flex Fixed Bearing Knee: Surgical Technique”, Zimmer, Inc., (2004, 2007, 2008), 16 pgs. |
“Mexican Application Serial No. MX/a/2013/000988, Office Action dated Mar. 18, 2015”, w/English Claims, 17 pgs. |
“Mexican Application Serial No. MX/a/2013/000988, Response filed Jun. 1, 2015 to Office Action dated Mar. 18, 2015”, (W/English Translation), 12 pgs. |
“Mexican Application Serial No. MX/A/2013/000988. Office Action dated Jun. 5, 2015”, w/summary in English, 6 pgs. |
“Mexican Application Serial No. MX/A/2013/000990, Final Office Action dated Feb. 4, 2016”, w/ summary in English, 4 pgs. |
“Mexican Application Serial No. MX/A/2013/000990, Office Action dated Feb. 19, 2015”, (W/English Translation), 4 pgs. |
“Mexican Application Serial No. MX/A/2013/000990, Response filed Apr. 29, 2015 to Office Action dated Feb. 19, 2015”, W/ English Claims, 18 pgs. |
“MIS Minimally Invasive Solution, The M/G Unicompartmental Knee Minimally Invasive Surgical Technique”, Zimmer, Inc. Nexgen Complete Knee Solution, 97-5791-02, (Aug. 14, 2008), 27 pgs. |
“Multi-Reference 4-in-1 Femoral Instrumentation Surgical Technique for NexGen Cruciate Retaining & NexGen Legacy Posterior Stabilized Knees”, Zimmer, Inc. Nexgen Complete Knee Solution, 97-5973-402 Rev. 1, (1998, 2000), 18 pgs. |
“Natural-Knee II Primary System Surgical Technique”, Zimmer, Inc., (2005), 48 pgs. |
“Nexgen Complete Knee Solution”, Extramedullary/Intramedullary Tibial Resector: Surgical Technique, Zimmer, Inc. 97-5997-002-00 Rev. 2, (2000, 2008, 2009), 28 pgs. |
“Nexgen Complete Knee Solution”, Extramedullary/Intramedullary Tibial Resector: Surgical Technique, Zimmer, Inc. 97-5997-02 Rev 1, (2000), 26 pgs. |
“Nexgen Complete Knee Solution for the Legacy Knee LPS-Flex Fixed Bearing Knee”, Zimmer Surgical Technique, 97-5964-102-00, (2004, 2007), 12 pgs. |
“NexGen Complete Knee Solution, Intramedullary Instrumentation Surgical Technique for the NexGen Cruciate Retaining & Legacy Posterior Stabilized Knee”, Zimmer, Inc., (1995, 1997, 1998), 1-33. |
“NexGen Implant Options Surgeon-Specific”, Zimmer Inc., (2000), 16 pgs. |
“NexGen LPS Fixed Knee: Surgical Technique”, Zimmer Inc., (2002, 2008), 44 pgs. |
“NexGen LPS-Flex Mobile and LPS-Mobile Bearing Knees”, Zimmer, Inc., (2007, 2008), 4 pgs. |
“NexGen Trabecular Metal Modular Plates”, Zimmer Inc., (2007), 19 pgs. |
“Persona “Medial Congruent Articular Surface” System Overview”, Zimmer, Inc., (2015), 6 pgs. |
“Persona “The Personalized Knee System””, Medial Congruent Sales Training, Zimmer, Inc., (Jul. 2015), 53 pgs. |
“Persona ”The Personalized Knee System“ Medial Congruent Advanced Bearings”, Zimmer, Inc., (2015), 2 pgs. |
“Persona “The Personalized Knee System” Medial Congruent Articular Surface Design Rationale”, Zimmer, Inc., (2015), 20 pgs. |
“Persona “The Personalized Knee System” Persona Medial Congruent”, Mar. 24-28, 2015 at the American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting., (Mar. 2015), 1 pg. |
“Persona “The Personalized Knee System” Surgical Technique”, Zimmer, Inc., (2015), 72 pgs. |
“Persona Medial Congruent Articular Surface”, Sales Training, Zimmer Biomet, (Jan. 2016), 71 pgs. |
“PFC Sigma Knee System with Rotating Platform Technical/ Monograph”, Depuy PFC Sigma RP, 0611-29-050 (Rev. 3), (1999), 70 pgs. |
“Primary/Revision Surgical Technique for NexGen Rotating Hinge Knee (RHK)”, Zimmer, Inc. Nexgen Complete Knee Solution, 97-5880-02, (2002), 116 pgs. |
“Revision Instrumentation Surgical Technique for Legacy Knee Constrained Condylar Knee”, Zimmer, Inc. Nexgen Complete Knee Solution, 97-5994-202, (2001), 61 pgs. |
“Russian Application Serial No. 2013106942, Office Action dated Apr. 16, 2015”, W/ English Translation, 5 pgs. |
“Russian Application Serial No. 2013106942, Response filed Jul. 15, 2015 Office Action dated Apr. 16, 2015”, (W/ English translation of claims), 146 pgs. |
“Russian Application Serial No. 2013106943, Office Action dated Jul. 1, 2015”, (W/ English Translation), 6 pgs. |
“Russian Application Serial No. 2013106943, Office Action dated Dec. 28, 2015”, w/ partial English Translation, 6 pgs. |
“Russian Application Serial No. 2013106943, Response filed Apr. 28, 2016 to Office Action dated Dec. 28, 2015”, (W/ English translation of claims), 19 pgs. |
“Russian Application Serial No. 2013106943, Response filed Oct. 30, 2015 to Office Action dated Jul. 1, 2015”, (W/ English translation of claims), 21 pgs. |
“South African Application Serial No. 2013/01327, Amendment filed Apr. 24, 2014”, W/ English Translation, 4 pgs. |
“South African Application Serial No. 2013/01328, Amendment filed Apr. 24, 2014”, W/ English Translation, 4 pgs. |
“Surgical Technique for Cruciate Retaining Knees and Revision Instrumentation Surgical Technique for Cruciate Retaining Augmentable Knees”, Zimmer, Inc. Nexgen Complete Knee Solution, 97-5970-202, (2002), 130 pgs. |
“Surgical Technique for the CR-Flex Fixed Bearing Knee”, NexGen Complete Knee Solution, Zimmer, Inc., (2003), 22 pgs. |
“Surgical Technique for the Legacy Knee LPS-Flex Fixed Bearing Knee”, Zimmer, Inc. Nexgen Complete Knee Solution, 97-5964-02, Rev. 1, (2000, 2002), 15 pgs. |
“Surgical Technique for the Legacy Posterior Stabilized Knees”, Zimmer, Inc. Nexgen Complete Knee Solution, 97-5996-02, (2002), 43 pgs. |
“Surgical Technique—Nexgen Complete Knee Solution for the Legacy Knee LPS—Flex Fixed Bearing Knee”, Zimmer, Inc., (2004, 2007), 12 pgs. |
“The Zimmer Institute Surgical Technique MIS Quad-Sparing Surgical Technique for Total Knee Arthroplasty”, NExGen Complete Knee Solution, (2004), 55 pgs. |
“Tibial Baseplate: Pocket Guide (United States Version)”, Zimmer, Inc.,, (2009), 17 pgs. |
“Trabecular Metal Monoblock Tibial Components”, Zimmer, Inc., (2007), 4 pgs. |
“Trabecular Metal Monoblock Tibial Components Surgical Technique Addendum”, Nexgen Zimmer, Inc., (2005, 2007), 12 pgs. |
“Trabecular Metal Tibial Tray: Surgical Technique”, NexGen Zimmer, Inc., (2007, 2009), 16 pgs. |
“Zimmer MIS Intramedullary Instrumentation Surgical Technique For NexGen Cruciate Retaining & NexGen Legacy Posterior Stabilized Knees”, printed 2005, 2009, Zimmer, Inc., (2009), 45 pgs. |
“Zimmer Nexgen Cruciate Retaining (CR) and Legacy Knee Posterior Stabilized (LPS) Trabecular Metal Monoblock Tibias”, Zimmer, Inc Surgical Technique Addendum, 97-7253-34, Rev. 3, (2004), 11 pgs. |
“Zimmer NexGen CR-Flex and LPS-Flex Knees Surgical Technique with posterior Referencing Instrumentation.”, Zimmer Inc., (2010, 2011), 48 pgs. |
“Zimmer NexGen LCCK Surgical Technique for use with LCCK 4-in-1 Instrumentation”, Zimmer, Inc.; copyright 2009, 2010, 2011, (May 2011), 52 pgs. |
“Zimmer NexGen MIS Modular Tibial Plate and Keel Cemented Surgical Technique”, Zimmer Inc., (2006, 2011), 26 pgs. |
“Zimmer NexGen MIS Tibial Component”, Brochure-97-5950-001-00 7.5mm, (2005, 2006), 8 pgs. |
“Zimmer NexGen MIS Tibial Component Cemented Surgical Technique”, Zimmer, Inc, #97-5950-002-00 Rev.1 1.5ML, (2005), 14 pgs. |
“Zimmer NexGen MIS Tibial Component Cemented Surgical Technique”, Zimmer Inc., (2005, 2006, 2008, 2009, 2010), 16 pgs. |
“Zimmer NexGen Trabecular Metal Augments—Abbreviated Surgical Technique”, Zimmer, Inc., (2004, 2006), 6 pgs. |
“Zimmer NexGen Trabecular Metal Augments Surgical Technique for LCCK & Rotating Hing Knee Trabecular Metal Augments”, Zimmer, Inc. 97-5448-02, Rev. 1, (2004), 6 pgs. |
“Zimmer NexGen Trabecular Metal Primary Patella Surgical Technique”, Zimmer. Inc., 97-7255-112-00, (2005), 10 pgs. |
“Zimmer NexGen Trabecular Metal Tibial Tray”, Surgical Technique, Zimmer, Inc., (2007, 2009), 16 pgs. |
“Zimmer Patient Specific Instruments”, Surgical Techniques for NexGen Complete Knee Solution Zimmer, Inc., (2010), 16 pgs. |
Annayappa, Ramesh, “Tibial Prosthesis”, U.S. Appl. No. 13/189,328, filed Jul. 22, 2011, 82 pgs. |
Annayappa, Ramesh, et al., “Tibial Prosthesis”, U.S. Appl. No. 13/189,324, filed Jul. 22, 2011, 50 pgs. |
Ding, M., et al., “Age-related variations in the microstructure of human tibial cancellous bone”, Journal of Orthopaedic Research, 20(3), (2002), 615-621. |
Ding, M., et al., “Changes in the three-dimensional microstructure of human tibial cancellous bone in early osteoarthritis”, Journal of Bone & Joint Surgery (British), 85-B(6), (Aug. 2003), 906-912. |
Doyle, et al., “Comparative Analysis of Human Trabecular Bone and Polyurethane Foam”, Purdue University., 1 pg. |
Dunbar, M. J., et al., “Fixation of a Trabecular Metal Knee Arthroplasty Component: A Prospective Randomized Study”, The Journal of Bone & Joint Surgery (American), vol. 91—A(7), (Jul. 2009), 1578-1586. |
Edwards, Andrew, et al., “The Attachments of the Fiber Bundles of the Posterior Cruciate ligament: An Anatomic Study”, Arthroscopy: The Journal of Arthroscopic and Related Surgery, vol. 23, No. 3, (Mar. 2008), 284-290. |
Freeman, M.A.R., et al., “The Movement of the Knee Studied by Magnetic Resonance Imaging”, Advanced Bearings—Clinical Orthopedics & Related Research 2003, (2003), 1 pg. |
Hofmann, Aaron A, et al., “Posterior Stabilization in Total Knee Arthroplasty with Use of an Ultracongruent Polyethylene”, The Journal of Arthroplasty vol. 15, No. 5, (2000), 576-583. |
Hvid, Ivan, et al., “Trabecular bone Strength Patterns at the Proximal Tibial Epiphysis”, Journal of Orthopaedic Research, vol. 3, No. 4, (1985), 464-472. |
Klostermann, et al., “Distribution of bone mineral density with age and gender in the proximal tibia”, Clinical Biomechanics 19, 376-376. |
Lorenz, Stephan, et al., “Radiological evaluation of the anterolateral and posteromedial bundle insertion sites of the posterior cruciate ligament”, Knee Surg Sports Traumatol Arthosc, vol. 17, (2009), 683-690. |
Moorman, Claude, et al., “Tibial Insertion of the Posterior Cruciate Ligament: A Sagittal Plane Analysis Using Gross, Histologic, and Radiographic Methods”, Arthroscopy: The Journal of Arthroscopic and Related Surgery, vol. 24, No. 3, (Mar. 2008), 269-275. |
Parisi, Raymond C, “Motion Facilitating Tibial Components for a Knee Prosthesis”, U.S. Appl. No. 13/229,103, filed Sep. 9, 2011, 46 pgs. |
Partovi, Hamid, “Flow-Through Latch and Edge-Triggered Flip-Flop Hybrid Elements”, Proceedings of the IEEE International Solid-State Circuits Conference, Digest of Technical Papers and Slide Supplement, NexGen Inc., Milpitas, CA, (1996), 40 pgs. |
Siggelkow, Eik, et al., “Impact of Tibia Bearing Surface and Femoral Component Design on Flexion Kinematics During Lunge”, Mar. 28-31, 2015 at the Orthopaedic Research Society (ORS) Annual Meeting (Poster #1645), (Mar. 2015), 1 pg. |
Siggelkow, Eik, et al., “Impact of Tibia Bearing Surface Design on Deep Knee Bend Kinematics”, Mar. 24-28, 2015 at the AAOS Conference (Poster #P142), (Mar. 2015), 1 pg. |
Stilling, et al., “Superior fixation of pegged trabecular metal over screw-fixed pegged porous titanium fiber mesh”, Acta Orthopaedica., (2011), 177-186. |
Wentorf, Mary S. S, “Asymmetric Tibial Components for a Knee Prosthesis”, U.S. Appl. No. 13/189,338, filed Jul. 22, 2011, 58 pgs. |
Wentorf, Mary S. S, “Asymmetric Tibial Components for a Knee Prosthesis”, U.S. Appl. No. 13/189,339, filed Jul. 22, 2011, 52 pgs. |
Wentorf, Mary S. S, “Asymmetric Tibial Components for a Knee Prosthesis”, U.S. Appl. No. 13/189,336, filed Jul. 22, 2011, 60 pgs. |
“U.S. Appl. No. 15/915,886, PTO Response to Rule 312 Communication dated May 8, 2020”, 2 pgs. |
“U.S. Appl. No. 15/971,743, Notice of Allowance dated Aug. 6, 2019”, 8 pgs. |
“U.S. Appl. No. 16/389,381, Non Final Office Action dated Mar. 30, 2020”, 9 pgs. |
“U.S. Appl. No. 16/675,938, Preliminary Amendment filed Jan. 22, 2020”, 7 pgs. |
“U.S. Appl. No. 16/715,092, Preliminary Amendment filed Mar. 19, 2020”, 10 pgs. |
“U.S. Appl. No. 16/743,746, Preliminary Amendment filed Mar. 19, 2020”, 8 pgs. |
“Australian Application Serial No. 2018266322, First Examination Report dated Dec. 19, 2019”, 2 pgs. |
“European Application Serial No. 18711801.3, Response to Communication pursuant to Rules 161(1) and 162 EPC filed May 7, 2020”, 14 pgs. |
“European Application Serial No. 19171990.5, Response filed May 13, 2020 to Extended European Search Report dated Oct. 16, 2019”, 31 pgs. |
“International Application Serial No. PCT/US201 8/031177, International Preliminary Report on Patentability dated Nov. 21, 2019”, 8 pgs. |
“International Application Serial No. PCT/US2018/031177, International Search Report dated Jul. 31, 2018”, 6 pgs. |
“International Application Serial No. PCT/US2018/031177, Written Opinion dated Jul. 31, 2018”, 6 pgs. |
“U.S. Appl. No. 15/915,886, Response filed Nov. 4, 2019 to Non-Final Office Action dated Aug. 2, 2019”, 8 pgs. |
“Brazil Application Serial No. BR1120130016698, Office Action dated Aug. 27, 2019”, 8 pgs. |
“Brazil Application Serial No. BR1120130016736, Office Action dated Aug. 27, 2019”, 8 pgs. |
“European Application Serial No. 16770657.1, Response filed Sep. 30, 2019 to Communication Pursuant to Article 94(3) EPC dated May 20, 2019”, 26 pgs. |
“European Application Serial No. 18206326.3, Extended European Search Report dated Apr. 15, 2019”, 10 pgs. |
“European Application Serial No. 19171990.5, Extended European Search Report dated Oct. 16, 2019”, 8 pgs. |
“Journey II XR, Bi-Cruciate Retaining Knee System”, Smith & Nephew, Surgical Technique, (2015), 40 pgs. |
“Vanguard® ID Total Knee, Surgical Technique”, Zimmer Biomet; 0682.1-GLBL-en-REV0317, (2017), 36 pgs. |
Bellemans, Johan, et al., “Is Neutral Mechanical Alignment Normal for All Patients?”, Clinical Orthopaedics and Related Research; DOI 10.1007/s11999-011-1936-5, (Jun. 9, 2011), 9 pgs. |
Hutt, Jonathan, et al.,, “Functional joint line obliquity after kinematic total knee arthroplasty”, International Orthopaedics; DOI 10.1007/s00264-015-2733-7, (Mar. 21, 2015), 6 pgs. |
Victor, Jan M. K., et al., “Constitutional Varus Does Not Affect Joint Line Orientation in the Coronal Plane”, Joint Line Orientation in the Coronal Plane; 472; DOI 10.1007/s11999-013-2898-6, (Jun. 4, 2013), pp. 98-104. |
“U.S. Appl. No. 14/471,440, Notice of Allowance dated Nov. 13, 2017”, 9 pgs. |
“U.S. Appl. No. 14/471,440, Response filed Aug. 16, 2017 to Restriction Requirement dated Jun. 30, 2017”, 8 pgs. |
“U.S. Appl. No. 14/471,440, Restriction Requirement dated Jun. 30, 2017”, 6 pgs. |
“U.S. Appl. No. 15/890,735, Notice of Allowance dated Oct. 29, 2019”, 11 pgs. |
“U.S. Appl. No. 15/915,886, Notice of Allowance dated Jan. 16, 2020”, 9 pgs. |
“Brazil Application Serial No. BR1120130016698, Response filed Dec. 9, 2019 to Office Action dated Aug. 27, 2019”, w/ English Claims, 22 pgs. |
“Brazil Application Serial No. BR1120130016736, Response filed Dec. 9, 2019 to Office Action dated Aug. 27, 2019”, w/ English Claims, 25 pgs. |
“European Application Serial No. 18206326.3, Response filed Nov. 22, 2019 to Extended European Search Report dated Apr. 15, 2019”, 15 pgs. |
“Indian Application Serial No. 1544/DELNP/2013, Response filed Nov. 18, 2019 to Office Action dated May 21, 2019”, w/ English claims, 34 pgs. |
“Indian Application Serial No. 1545/DELNP/2013, Office Action dated Dec. 9, 2019”, (with English translation), 8 pages. |
“Turkish Application Serial No. 11808493.8, Working Requirements dated Feb. 17, 2020”, 3 pgs. |
“U.S. Appl. No. 16/179,201, Examiner Interview Summary dated Feb. 8, 2021”, 3 pgs. |
“U.S. Appl. No. 16/179,201, Non Final Office Action dated Nov. 2, 2020”, 15 pgs. |
“U.S. Appl. No. 16/179,201, Response filed Jan. 28, 2021 to Non Final Office Action dated Nov. 2, 2020”, 16 pgs. |
“U.S. Appl. No. 16/179,201, Response filed Oct. 5, 2020 to Restriction Requirement dated Aug. 7, 2020”, 9 pgs. |
“U.S. Appl. No. 16/179,201, Restriction Requirement dated Aug. 7, 2020”, 10 pgs. |
“U.S. Appl. No. 16/179,201, Supplemental Amendment & Response filed Feb. 19, 2021 to Non-Final Office Action Filed Nov. 2, 2020”, 17 pgs. |
“U.S. Appl. No. 16/352,287, Non Final Office Action dated Dec. 10, 2020”, 12 pgs. |
“U.S. Appl. No. 16/352,287, Response filed Feb. 22, 2021 to Non Final Office Action dated Dec. 10, 2020”, 14 pgs. |
“U.S. Appl. No. 16/352,287, Response filed Oct. 12, 2020 to Restriction Requirement dated Aug. 17, 2020”, 8 pgs. |
“U.S. Appl. No. 16/352,287, Restriction Requirement dated Aug. 17, 2020”, 6 pgs. |
“U.S. Appl. No. 16/389,381, Notice of Allowance dated Jul. 16, 2020”, 5 pgs. |
“U.S. Appl. No. 16/389,381, Response filed Jun. 19, 2020 to Non Final Office Action dated Mar. 30, 2020”, 9 pgs. |
“U.S. Appl. No. 16/849,394, Preliminary Amendment filed Jun. 3, 2020”, 7 pgs. |
“U.S. Appl. No. 17/068,435, Preliminary Amendment filed Nov. 13, 2020”, 7 pgs. |
“Brazilian Application Serial No. BR1120130016736, Response filed Oct. 5, 2020 to Office Action dated Jun. 10, 2020”, (W/ English Translation of Claims), 91 pages. |
“Canadian Application Serial No. 3,063,415, Office Action dated Jul. 13, 2020”, 3 pgs. |
“Canadian Application Serial No. 3,063,415, Response filed Nov. 12, 2020 to Office Action dated Jul. 13, 2020”, 15 pgs. |
“Chinese Application Serial No. 201880016775.4, Office Action dated Jan. 22, 2021”, (W/English Translation), 15 pgs. |
“Chinese Application Serial No. 201880031319.7, Office Action dated May 15, 2020”, (W/ English Translation), 12 pgs. |
“Chinese Application Serial No. 201880031319.7, Office Action dated Nov. 18, 2020”, with English translation, 9 pgs. |
“Chinese Application Serial No. 201880031319.7, Response filed Jan. 18, 2021 to Office Action dated Nov. 18, 2020”, with English claims, 16 pgs. |
“Chinese Application Serial No. 201880031319.7, Response filed Jul. 22, 2020 to Office Action dated May 15, 2020”, (W/ English Claims), 10 pgs. |
“European Application Serial No. 18726670.5, Response to Communication pursuant to Rules 161(1) and 162 EPC filed Jul. 20, 2020”, 9 pgs. |
“Indian Application Serial No. 1545/DELNP/2013, Response filed Jun. 9, 2020 to Office Action dated Dec. 9, 2019”, (W/ English Claims), 78 pgs. |
“Japanese Application Serial No. 2019-562605, Notification of Reasons for Refusal dated Jun. 16, 2020”, (W/ English Translation), 7 pgs. |
“Japanese Application Serial No. 2019-562605, Notification of Reasons for Refusal dated Nov. 10, 2020”, with English translation, 5 pgs. |
“Japanese Application Serial No. 2019-562605, Response filed Feb. 9, 2021 to Notification of Reasons for Refusal dated Nov. 10, 2020”, w/English claims, 19 pgs. |
“Japanese Application Serial No. 2019-562605, Response filed Sep. 15, 2020 to Notification of Reasons for Refusal dated Jun. 16, 2020”, (W/ English Claims), 15 pgs. |
“U.S. Appl. No. 16/179,201, Advisory Action dated Jun. 25, 2021”, 3 pgs. |
“U.S. Appl. No. 16/179,201, Final Office Action dated Apr. 20, 2021”, 11 pgs. |
“U.S. Appl. No. 16/179,201, Response filed Jun. 18, 2021 to Final Office Action dated Apr. 20, 2021”, 16 pgs. |
“U.S. Appl. No. 16/352,287, Final Office Action dated May 25, 2021”, 8 pgs. |
“U.S. Appl. No. 16/352,287, Notice of Allowance dated Jun. 30, 2021”, 7 pgs. |
“U.S. Appl. No. 16/352,287, Response filed Jun. 18, 2021 to Final Office Action dated May 25, 2021”, 8 pgs. |
“U.S. Appl. No. 16/530,423, Non Final Office Action dated May 17, 2021”, 10 pgs. |
“U.S. Appl. No. 16/715,092, Response filed Aug. 11, 2021 to Non Final Office Action dated May 17, 2021”, 15 pgs. |
“U.S. Appl. No. 16/715,092, Response filed Aug. 9, 2021 to Restriction Requirement dated Jun. 25, 2021”, 7 pgs. |
“U.S. Appl. No. 16/715,092, Restriction Requirement dated Jun. 25, 2021”, 6 pgs. |
“Australian Application Serial No. 2020204019, First Examination Report dated Jun. 18, 2021”, 7 pgs. |
“Chinese Application Serial No. 201880016775.4, Decision of Rejection dated Jul. 12, 2021”, (W/ English Translation), 13 pgs. |
“European Application Serial No. 16189084.3, Communication Pursuant to Article 94(3) EPC dated Jul. 1, 2021”, 6 pgs. |
Number | Date | Country | |
---|---|---|---|
20200030106 A1 | Jan 2020 | US |
Number | Date | Country | |
---|---|---|---|
61381800 | Sep 2010 | US | |
61367375 | Jul 2010 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15827654 | Nov 2017 | US |
Child | 16596194 | US | |
Parent | 14034937 | Sep 2013 | US |
Child | 15827654 | US | |
Parent | 13189336 | Jul 2011 | US |
Child | 14034937 | US |